Contact

All Stories

  1. The Association between Glucose 6-Phosphate Dehydrogenase Deficiency and Attention Deficit/Hyperactivity Disorder

    Article • Nutrients, November 2023, MDPI AG

    Prof ABRAHAM WEIZMAN

  2. Differences in Telomere Length between Adolescent Females with Anorexia Nervosa Restricting Type and Anorexia Nervosa Binge-Purge Type

    Article • Nutrients, June 2023, MDPI AG

    Prof ABRAHAM WEIZMAN

  3. Clozapine Suppresses the Gene Expression and the Production of Cytokines and Up-Regulates Cyclooxygenase 2 mRNA in Human Astroglial Cells

    Article • Brain Sciences, December 2022, MDPI AG

    Prof ABRAHAM WEIZMAN

  4. The Association between Somatotropin Therapy and the Risk of SARS-CoV-2 Infection in Children with Short Stature: A Population-Based Cross-Sectional Study

    Article • Children, November 2022, MDPI AG

    Prof ABRAHAM WEIZMAN

  5. Clinical and Socio-Demographic Variables Associated with the Diagnosis of Long COVID Syndrome in Youth: A Population-Based Study

    Article • International Journal of Environmental Research and Public Health, May 2022, MDPI AG

    Prof ABRAHAM WEIZMAN

  6. The Effect of Natural-Based Formulation (NBF) on the Response of RAW264.7 Macrophages to LPS as an In Vitro Model of Inflammation

    Article • Journal of Fungi, March 2022, MDPI AG

    Prof ABRAHAM WEIZMAN

  7. Complex Effects of Sertraline and Citalopram on In Vitro Murine Breast Cancer Proliferation and on In Vivo Progression and Anxiety Level

    Article • International Journal of Molecular Sciences, February 2022, MDPI AG

    Prof ABRAHAM WEIZMAN

  8. Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review

    Article • International Journal of Environmental Research and Public Health, January 2022, MDPI AG

    Prof ABRAHAM WEIZMAN

  9. The Neuro-Protective Effects of the TSPO Ligands CB86 and CB204 on 6-OHDA-Induced PC12 Cell Death as an In Vitro Model for Parkinson’s Disease

    Article • Biology, November 2021, MDPI AG

    Prof ABRAHAM WEIZMAN

  10. Mood and Proneness to Boredom Are Associated with Poorer Continuous Performance Test Results, Which May Improve with Methylphenidate Treatment, in Attention-Deficit/Hyperactivity Disorder

    Article • Journal of Child and Adolescent Psychopharmacology, May 2021, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  11. The TSPO Ligands MGV-1 and 2-Cl-MGV-1 Differentially Inhibit the Cigarette Smoke-Induced Cytotoxicity to H1299 Lung Cancer Cells

    Article • Biology, May 2021, MDPI AG

    Prof ABRAHAM WEIZMAN

  12. The Potential Usefulness Of The Social Attribution Task (SAT) in Diagnosing Girls with ASD

    Article • International Journal of Disability Development and Education, April 2021, Taylor & Francis

    Dr. Shahar Gindi, Prof ABRAHAM WEIZMAN

  13. Body mass index increase in preschoolers with heterogeneous psychiatric diagnoses treated with risperidone

    Article • Journal of Psychopharmacology, April 2021, SAGE Publications

    Prof ABRAHAM WEIZMAN

  14. COVID-19 pandemic: Impacts on mothers’ and infants’ mental health during pregnancy and shortly thereafter

    Article • Clinical Child Psychology and Psychiatry, April 2021, SAGE Publications

    Prof ABRAHAM WEIZMAN

  15. Association between Adherence to SSRI Treatment and Mortality among Individuals with Metabolic Syndrome Components

    Article • Pharmacopsychiatry, April 2021, Thieme Publishing Group

    Prof ABRAHAM WEIZMAN

  16. The Association between ADHD and the Severity of COVID-19 Infection

    Article • Journal of Attention Disorders, April 2021, SAGE Publications

    Prof ABRAHAM WEIZMAN

  17. Elevated rate of OCD-spectrum and tic disorders in patients with bipolar depression and comorbid OCD

    Article • Journal of Obsessive-Compulsive and Related Disorders, April 2021, Elsevier

    Prof ABRAHAM WEIZMAN

  18. Chronic opipramol treatment extinguishes cocaine craving through Rac1 in responders: A rat model study

    Article • Addiction Biology, January 2021, Wiley

    Tzofnat Bareli, Prof ABRAHAM WEIZMAN

  19. Phenotypic Characterization of Youth Admitted To Acute Psychiatric Inpatient Unit Following Self-Harm Behavior

    Article • Archives of Suicide Research, January 2021, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  20. Development and validation of a machine learning‐based postpartum depression prediction model: A nationwide cohort study

    Article • Depression and Anxiety, December 2020, Hindawi Publishing Corporation

    Prof ABRAHAM WEIZMAN

  21. Metabolic predictors for mortality among patients treated with long-term clozapine – A longitudinal study

    Article • European Neuropsychopharmacology, December 2020, Elsevier

    Prof ABRAHAM WEIZMAN

  22. An increase in IL-6 levels at 6-month follow-up visit is associated with SSRI-emergent suicidality in high-risk children and adolescents treated with fluoxetine

    Article • European Neuropsychopharmacology, November 2020, Elsevier

    Prof ABRAHAM WEIZMAN

  23. Thyroid function assessment before and after diagnosis of schizophrenia: A community-based study

    Article • Psychiatry Research, November 2020, Elsevier

    Prof ABRAHAM WEIZMAN

  24. Management of anxiety disorders in children with attention-deficit hyperactivity disorder: a narrative review

    Article • International Clinical Psychopharmacology, October 2020, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  25. Liposomal Carrier Conjugated to APP-Derived Peptide for Brain Cancer Treatment

    Article • Cellular and Molecular Neurobiology, October 2020, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  26. Psychopharmacology in the Pediatric Oncology and Bone Marrow Transplant Units: Antipsychotic Medications Palliate Symptoms in Children with Cancer

    Article • Journal of Child and Adolescent Psychopharmacology, October 2020, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  27. The Efficacy of the Novel TSPO Ligands 2-Cl-MGV-1 and 2,4-Di-Cl-MGV-1 Compared to the Classical TSPO Ligand PK 11195 to Counteract the Release of Chemokines from LPS-Stimulated BV-2 Microglial Cells

    Article • Biology, September 2020, MDPI AG

    Prof ABRAHAM WEIZMAN

  28. Beneficial Effect of a Relatively Low Dose of Clozapine in a Bipolar Depression Patient With Comorbid Obsessive-Compulsive Disorder and Severe Suicidality

    Article • Clinical Neuropharmacology, August 2020, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  29. Beneficial effect of quetiapine monotherapy in patients with bipolar depression and comorbid obsessive-compulsive disorder

    Article • International Clinical Psychopharmacology, August 2020, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  30. Lack of association between unipolar or bipolar depression and serum aquaporin-4 autoantibodies

    Article • Brain Behavior and Immunity, August 2020, Elsevier

    Prof ABRAHAM WEIZMAN

  31. Regulatory effect of lithium on hippocampal blood‐brain barrier integrity in a rat model of depressive‐like behavior

    Article • Bipolar Disorders, July 2020, Wiley

    Prof ABRAHAM WEIZMAN

  32. ADHD as a Risk Factor for Infection With Covid-19

    Article • Journal of Attention Disorders, July 2020, SAGE Publications

    Prof ABRAHAM WEIZMAN

  33. Pharmacotherapy of attention-deficit hyperactivity disorder: common quandaries, dilemmas and challenges

    Article • International Clinical Psychopharmacology, July 2020, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  34. Increased circulatory IL-6 during 8-week fluoxetine treatment is a risk factor for suicidal behaviors in youth

    Article • Brain Behavior and Immunity, July 2020, Elsevier

    Prof ABRAHAM WEIZMAN

  35. Seminars in Clinical Psychopharmacology

    Article • May 2020, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  36. The association of non-suicidal self-injurious and suicidal behaviors with religiosity in hospitalized Jewish adolescents

    Article • Clinical Child Psychology and Psychiatry, May 2020, SAGE Publications

    Prof ABRAHAM WEIZMAN

  37. Personality Traits and Psychotic Proneness Among Chronic Synthetic Cannabinoid Users

    Article • Frontiers in Psychiatry, May 2020, Frontiers

    Prof ABRAHAM WEIZMAN

  38. Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT2a Receptor Antagonists

    Article • Drugs, May 2020, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  39. Liposome-based targeting of dopamine to the brain: a novel approach for the treatment of Parkinson’s disease

    Article • Molecular Psychiatry, May 2020, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  40. Efficaciousness of Low Affinity Compared to High Affinity TSPO Ligands in the Inhibition of Hypoxic Mitochondrial Cellular Damage Induced by Cobalt Chloride in Human Lung H1299 Cells

    Article • Biomedicines, May 2020, MDPI AG

    Prof ABRAHAM WEIZMAN

  41. Association of Risperidone Treatment and Change in BMI in Children Under 5 Years Old: A Retrospective Cohort Study

    Article • Biological Psychiatry, May 2020, Elsevier

    Prof ABRAHAM WEIZMAN

  42. The Effect of Clozapine and Another Antipsychotic Combination Treatment on the Clinical Outcomes of Treatment Resistant Schizophrenia Inpatients

    Article • Biological Psychiatry, May 2020, Elsevier

    Prof ABRAHAM WEIZMAN

  43. Differential methylation of imprinting genes and MHC locus in 22q11.2 deletion syndrome-related schizophrenia spectrum disorders

    Article • The World Journal of Biological Psychiatry, April 2020, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  44. Levels of Proneness to Boredom in Children with Attention-Deficit/Hyperactivity Disorder On and Off Methylphenidate Treatment

    Article • Journal of Child and Adolescent Psychopharmacology, April 2020, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  45. Comorbid personality disorders in manic bipolar I disorder patients is associated with increased use of long-acting injectable antipsychotic treatment and higher rates of rehospitalization

    Article • International Clinical Psychopharmacology, March 2020, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  46. Effects of country of origin and wave of immigration on prevalence of schizophrenia among first and second-generation immigrants: A 30-year retrospective study

    Article • Schizophrenia Research, March 2020, Elsevier

    Prof ABRAHAM WEIZMAN

  47. Poor performance of the ‘child Reading the Mind in the Eyes Test’ correlates with poorer social-emotional functioning in children with attention-deficit/hyperactivity disorder

    Article • International Clinical Psychopharmacology, March 2020, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  48. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion

    Article • Molecular Psychiatry, February 2020, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN, Dr. Carrie E Bearden

  49. The Placebo Response in Adult ADHD as Objectively Assessed by the TOVA Continuous Performance Test

    Article • Journal of Attention Disorders, January 2020, SAGE Publications

    Prof ABRAHAM WEIZMAN

  50. Long-term effects of intracranial islet grafting on cognitive functioning in a rat metabolic model of sporadic Alzheimer's disease-like dementia

    Article • PLoS ONE, January 2020, PLOS

    Prof ABRAHAM WEIZMAN, Dr Konstantin Bloch

  51. Low levels of serum vitamin D in clozapine-treated schizophrenia patients are associated with high levels of the proinflammatory cytokine IL-6

    Article • International Clinical Psychopharmacology, January 2020, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  52. 18-kDa Translocator Protein Ligands Protect H9C2 Cardiomyocytes from Cigarette Smoke-induced Cell Death: In Vitro Study

    Article • In Vivo, January 2020, International Institute of Anticancer Research

    Prof ABRAHAM WEIZMAN

  53. Complete Sequence of the 22q11.2 Allele in 1,053 Subjects with 22q11.2 Deletion Syndrome Reveals Modifiers of Conotruncal Heart Defects

    Article • The American Journal of Human Genetics, January 2020, Elsevier

    Prof ABRAHAM WEIZMAN, Dr. Carrie E Bearden

  54. A history of prolonged childhood sexual abuse is associated with more severe clinical presentation of borderline personality disorder in adolescent female inpatients – A naturalistic study

    Article • Child Abuse & Neglect, December 2019, Elsevier

    Prof ABRAHAM WEIZMAN

  55. The role of inhibition capacities in the Iowa gambling test performance in young tattooed women

    Article • BMC Psychology, December 2019, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  56. Association between prenatal exposure to a 1-month period of repeated rocket attacks and neuropsychiatric outcomes up through age 9: a retrospective cohort study

    Article • European Child & Adolescent Psychiatry, November 2019, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  57. A retrospective case series of electroconvulsive therapy in the management of comorbid depression and anorexia nervosa

    Article • International Journal of Eating Disorders, October 2019, Wiley

    Prof ABRAHAM WEIZMAN

  58. Cigarette smoke, saliva, the translocator protein 18 kDa (TSPO), and oral cancer

    Article • Oral Diseases, October 2019, Wiley

    Prof ABRAHAM WEIZMAN

  59. The contribution of ADHD and attachment difficulties to online pornography use among students

    Article • Comprehensive Psychiatry, August 2019, Elsevier

    Prof ABRAHAM WEIZMAN

  60. Adherence to antidepressant medications is associated with reduced premature mortality in patients with cancer: A nationwide cohort study

    Article • Depression and Anxiety, July 2019, Wiley

    Prof ABRAHAM WEIZMAN

  61. Effects of Cigarette Smoke on TSPO-related Mitochondrial Processes

    Article • Cells, July 2019, MDPI AG

    Prof ABRAHAM WEIZMAN

  62. The effectiveness of high-dose escitalopram in the treatment of patients suffering from schizophrenia with comorbid obsessive-compulsive disorder

    Article • International Clinical Psychopharmacology, July 2019, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  63. Trafficking of Grafted Pancreatic Islets Into the Brain Lateral Ventricles

    Article • Transplantation, June 2019, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  64. Inhibitory Effects of the Two Novel TSPO Ligands 2-Cl-MGV-1 and MGV-1 on LPS-induced Microglial Activation

    Article • Cells, May 2019, MDPI AG

    Prof ABRAHAM WEIZMAN

  65. Add-on benzodiazepines for psychosis-induced aggression

    Article • International Clinical Psychopharmacology, May 2019, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  66. High pretreatment cognitive impulsivity predicts response of oppositional symptoms to methylphenidate in patients with attention-deficit hyperactivity disorder/oppositional defiant disorder

    Article • International Clinical Psychopharmacology, May 2019, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  67. Psychiatrists' attitude towards the use of clozapine in the treatment of refractory schizophrenia: A nationwide survey

    Article • Psychiatry Research, May 2019, Elsevier

    Prof ABRAHAM WEIZMAN

  68. The complexity of the interaction between binge-eating and attention

    Article • PLoS ONE, April 2019, PLOS

    Prof ABRAHAM WEIZMAN, Professor Daniel Stein, Yehuda Pollak

  69. Modulatory effects of cannabinoids on brain neurotransmission

    Article • European Journal of Neuroscience, April 2019, Wiley

    Prof ABRAHAM WEIZMAN

  70. Effectiveness and side effects of psychopharmacotherapy in individuals with 22q11.2 deletion syndrome with comorbid psychiatric disorders: a systematic review

    Article • European Child & Adolescent Psychiatry, April 2019, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  71. Positive and Negative Effects of Cannabis and Cannabinoids on Health

    Article • Clinical Pharmacology & Therapeutics, March 2019, Wiley

    Prof ABRAHAM WEIZMAN

  72. Predictors of suicidal behaviors during hospitalization among adolescents admitted due to suicidal behaviors: A 10-year retrospective naturalistic study

    Article • Archives of Suicide Research, March 2019, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  73. Equine Assisted Therapy for Patients with Post Traumatic Stress Disorder: A Case Series Study

    Article • Military Medicine, March 2019, Oxford University Press (OUP)

    Prof ABRAHAM WEIZMAN

  74. Apparent lack of practice effects in the Test of Variables of Attention (TOVA) in adult ADHD

    Article • ADHD Attention Deficit and Hyperactivity Disorders, March 2019, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  75. Cannabidiol as a suggested candidate for treatment of autism spectrum disorder

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, March 2019, Elsevier

    Prof ABRAHAM WEIZMAN

  76. Comparing executive functioning and clinical and sociodemographic characteristics of people with schizophrenia who hold a driver’s license to those who do not

    Article • Canadian Journal of Occupational Therapy, February 2019, SAGE Publications

    Prof ABRAHAM WEIZMAN

  77. The TSPO Ligands 2-Cl-MGV-1, MGV-1, and PK11195 Differentially Suppress the Inflammatory Response of BV-2 Microglial Cell to LPS

    Article • International Journal of Molecular Sciences, January 2019, MDPI AG

    Prof ABRAHAM WEIZMAN

  78. Do young women with tattoos have lower self-esteem and body image than their peers without tattoos? A non-verbal repertory grid technique approach

    Article • PLoS ONE, January 2019, PLOS

    Prof ABRAHAM WEIZMAN

  79. Risk gene-set and pathways in 22q11.2 deletion-related schizophrenia: a genealogical molecular approach

    Article • Translational Psychiatry, January 2019, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  80. Beneficial Effect of Betahistine, a Structural Analog of Histamine, in Clozapine-Related Sedation

    Article • Clinical Neuropharmacology, January 2019, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  81. Personality disorder comorbidity and rehospitalization rates in bipolar disorder: A cohort study

    Article • European Neuropsychopharmacology, January 2019, Elsevier

    Prof ABRAHAM WEIZMAN

  82. Distinct Response Inhibition Patterns in Obsessive Compulsive Disorder Patients and Pathological Gamblers

    Article • Frontiers in Psychiatry, December 2018, Frontiers

    Prof ABRAHAM WEIZMAN

  83. Very Low-Dose Mirtazapine (7.5 mg) in Treatment of Acute Antipsychotic-Associated Akathisia

    Article • Journal of Clinical Psychopharmacology, December 2018, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  84. The effect of methylphenidate treatment on psychopathic behavior of patients having attention-deficit hyperactivity disorder with and without oppositional defiant disorder

    Article • International Clinical Psychopharmacology, November 2018, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  85. The role of gender in association between inhibition capacities and risky decision making

    Article • Psychology Research and Behavior Management, October 2018, Dove Medical Press

    Professor Pinhas N Dannon, Prof ABRAHAM WEIZMAN

  86. Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjects

    Article • American Journal of Medical Genetics Part A, October 2018, Wiley

    stefano vicari, Prof ABRAHAM WEIZMAN, Dr. Carrie E Bearden

  87. Differences in demographic and clinical characteristics between cannabis users and non-drug users: A retrospective study of patients at first hospitalization due to psychotic symptoms

    Article • Psychiatry Research, October 2018, Elsevier

    Prof ABRAHAM WEIZMAN

  88. Intracranial Transplantation of Pancreatic Islets Attenuates Cognitive and Peripheral Metabolic Dysfunctions in a Rat Model of Sporadic Alzheimer’s Disease

    Article • Journal of Alzheimer’s Disease, September 2018, IOS Press

    Prof ABRAHAM WEIZMAN

  89. A DNA Methylation Signature of Addiction in T Cells and Its Reversal With DHEA Intervention

    Article • Frontiers in Molecular Neuroscience, September 2018, Frontiers

    Prof ABRAHAM WEIZMAN

  90. Obsessive-compulsive symptomatology in female adolescent inpatients with restrictive compared with binge-purge eating disorders

    Article • European Eating Disorders Review, September 2018, Wiley

    Professor Daniel Stein, Prof ABRAHAM WEIZMAN

  91. An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME)

    Article • Colorectal Disease, September 2018, Wiley

    Mostafa Shalaby, Dale Vimalachandran, Prof ABRAHAM WEIZMAN, Dr Dejan Ignjatovic, Dr Salomone Di Saverio, Dr Massimiliano Mistrangelo, Vicent Primo Romaguera

  92. Association of mechanical bowel preparation with oral antibiotics and anastomotic leak following left sided colorectal resection: an international, multi-centre, prospective audit

    Article • Colorectal Disease, September 2018, Wiley

    Mostafa Shalaby, Dale Vimalachandran, Prof ABRAHAM WEIZMAN, Dr Dejan Ignjatovic, Dr Salomone Di Saverio, Dr Massimiliano Mistrangelo, Vicent Primo Romaguera

  93. Evaluating the incidence of pathological complete response in current international rectal cancer practice: the barriers to widespread safe deferral of surgery

    Article • Colorectal Disease, September 2018, Wiley

    Mostafa Shalaby, Dale Vimalachandran, Prof ABRAHAM WEIZMAN, Dr Dejan Ignjatovic, Dr Salomone Di Saverio, Dr Massimiliano Mistrangelo, Vicent Primo Romaguera

  94. Safety of primary anastomosis following emergency left sided colorectal resection: an international, multi-centre prospective audit

    Article • Colorectal Disease, September 2018, Wiley

    Mostafa Shalaby, Dale Vimalachandran, Prof ABRAHAM WEIZMAN, Dr Dejan Ignjatovic, Dr Salomone Di Saverio, Dr Massimiliano Mistrangelo, Vicent Primo Romaguera

  95. The impact of conversion on the risk of major complication following laparoscopic colonic surgery: an international, multicentre prospective audit

    Article • Colorectal Disease, September 2018, Wiley

    Mostafa Shalaby, Dale Vimalachandran, Prof ABRAHAM WEIZMAN, Dr Dejan Ignjatovic, Dr Salomone Di Saverio, Dr Massimiliano Mistrangelo, Vicent Primo Romaguera

  96. Retraction Notice to: Nested Inversion Polymorphisms Predispose Chromosome 22q11.2 to Meiotic Rearrangements

    Article • The American Journal of Human Genetics, September 2018, Elsevier

    Prof ABRAHAM WEIZMAN, Dr. Carrie E Bearden

  97. The Impact of Prolonged, Selective, Serotonin Reuptake Inhibitor Treatment on Serum Lipid and Glucose Levels in Children and Adolescents: A Preliminary Prospective Study

    Article • Journal of Child and Adolescent Psychopharmacology, September 2018, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  98. Effectiveness of parental training, methylphenidate treatment, and their combination on academic achievements and behavior at school of children with attention-deficit hyperactivity disorder

    Article • International Clinical Psychopharmacology, July 2018, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  99. Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome

    Article • European Child & Adolescent Psychiatry, June 2018, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  100. Characterizing the Placebo Response in Adults With ADHD

    Article • Journal of Attention Disorders, June 2018, SAGE Publications

    Prof ABRAHAM WEIZMAN

  101. Citizen petition: Sexual side effects of SSRIs and SNRIs

    Article • International Journal of Risk & Safety in Medicine, June 2018, IOS Press

    Prof ABRAHAM WEIZMAN

  102. Demographic and Clinical Predictors of Hospitalization in Preschoolers With ADHD

    Article • Journal of Attention Disorders, May 2018, SAGE Publications

    Prof ABRAHAM WEIZMAN

  103. Elevated neutrophil to lymphocyte ratio in non-affective psychotic adolescent inpatients: Evidence for early association between inflammation and psychosis

    Article • Psychiatry Research, April 2018, Elsevier

    Prof ABRAHAM WEIZMAN

  104. Adjunctive antidepressants in bipolar depression: A cohort study of six- and twelve-months rehospitalization rates

    Article • European Neuropsychopharmacology, March 2018, Elsevier

    Prof ABRAHAM WEIZMAN

  105. No apparent association between bipolar disorder and cancer in a large epidemiological study of outpatients in a managed care population

    Article • International Clinical Psychopharmacology, March 2018, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  106. Changes in consumption of opioid analgesics in Israel 2009 to 2016: An update focusing on oxycodone and fentanyl formulations

    Article • Pharmacoepidemiology and Drug Safety, February 2018, Wiley

    Prof ABRAHAM WEIZMAN

  107. Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment

    Article • Schizophrenia Research, February 2018, Elsevier

    Prof ABRAHAM WEIZMAN

  108. An exploratory study of adolescent response to fluoxetine using psychological and biological predictors

    Article • PeerJ, January 2018, PeerJ

    Prof ABRAHAM WEIZMAN

  109. Dehydroepiandrosterone and Addiction

    Article • January 2018, Elsevier

    Prof ABRAHAM WEIZMAN

  110. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study

    Article • European Psychiatry, January 2018, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  111. Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits

    Article • The Journal of Clinical Psychiatry, December 2017, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  112. Possible Age-Related Progression of Attentional Impairment in ADHD and Its Attenuation by Past Diagnosis and Treatment

    Article • Journal of Attention Disorders, December 2017, SAGE Publications

    Prof ABRAHAM WEIZMAN

  113. Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial

    Article • EBioMedicine, December 2017, Elsevier

    Prof ABRAHAM WEIZMAN

  114. Higher adaptive functioning and lower rate of psychotic comorbidity in married versus unmarried individuals with 22q11.2 deletion syndrome

    Article • American Journal of Medical Genetics Part A, November 2017, Wiley

    Prof ABRAHAM WEIZMAN

  115. Low adherence to antidepressants is associated with increased mortality in Parkinson disease patients

    Article • Parkinsonism & Related Disorders, October 2017, Elsevier

    Prof ABRAHAM WEIZMAN

  116. Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: A two-site study

    Article • Schizophrenia Research, October 2017, Elsevier

    Prof ABRAHAM WEIZMAN

  117. RETRACTED: Nested Inversion Polymorphisms Predispose Chromosome 22q11.2 to Meiotic Rearrangements

    Article • The American Journal of Human Genetics, October 2017, Elsevier

    Prof ABRAHAM WEIZMAN, Dr. Carrie E Bearden

  118. Runs of homozygosity, copy number variation, and risk for depression and suicidal behavior in an Arab Bedouin kindred

    Article • Psychiatric Genetics, October 2017, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  119. 4.45 Clinical Manifestations of 22q11.2 Deletion Syndrome and the Role of Prematurity in the Emergence of Psychosis

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, October 2017, Elsevier

    Prof ABRAHAM WEIZMAN

  120. The effect of methylphenidate treatment on suspiciousness in children with ADHD alone or comorbid with ODD

    Article • International Journal of Psychiatry in Clinical Practice, September 2017, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  121. In vitro Effects of the Specific Mitochondrial TSPO Ligand Ro5 4864 in Cultured Human Osteoblasts

    Article • Experimental and Clinical Endocrinology & Diabetes, September 2017, Thieme Publishing Group

    Prof ABRAHAM WEIZMAN

  122. The Effectiveness of a Knowledge Translation Cognitive-Educational Intervention for Family Members of Persons Coping with Severe Mental Illness

    Article • Community Mental Health Journal, September 2017, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  123. The effect of methylphenidate on anxiety and depression symptoms in patients with Asperger syndrome and comorbid attention deficit/hyperactivity disorder

    Article • International Clinical Psychopharmacology, September 2017, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  124. Intracerebroventricular Streptozotocin Induces Obesity and Dementia in Lewis Rats

    Article • Journal of Alzheimer’s Disease, August 2017, IOS Press

    Dr Konstantin Bloch, Prof ABRAHAM WEIZMAN

  125. inflammatory markers and clinical outcome in treatment resistant schizophrenia inpatients treated with clozapine

    Article • August 2017, Morressier

    Prof ABRAHAM WEIZMAN

  126. Adjunctive antidepressants to mood stabilizers or atypical antipsychotics in bipolar depression and 1-year rehospitalization rates: a cohort study

    Article • July 2017, Morressier

    Prof ABRAHAM WEIZMAN

  127. The Possible Effect of Methylphenidate Treatment on Empathy in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder, Both With and Without Comorbid Oppositional Defiant Disorder

    Article • Journal of Child and Adolescent Psychopharmacology, June 2017, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  128. BDNF overexpression prevents cognitive deficit elicited by adolescent cannabis exposure and host susceptibility interaction

    Article • Human Molecular Genetics, April 2017, Oxford University Press (OUP)

    Prof ABRAHAM WEIZMAN

  129. Ketamine upregulates eNOS expression in human astroglial A172 cells: Possible role in its antidepressive properties

    Article • Journal of Neuroimmunology, April 2017, Elsevier

    Prof ABRAHAM WEIZMAN

  130. New developments in brain research of internet and gaming disorder

    Article • Neuroscience & Biobehavioral Reviews, April 2017, Elsevier

    Prof ABRAHAM WEIZMAN

  131. Trans-generation enrichment of clozapine-responsiveness trait in mice using a subchronic hypo-glutamatergic model of schizophrenia:A preliminary study

    Article • Behavioural Brain Research, April 2017, Elsevier

    Prof ABRAHAM WEIZMAN

  132. Serum Ferritin Levels Are Lower in Children With Tic Disorders Compared with Children Without Tics: A Cross-Sectional Study

    Article • Journal of Child and Adolescent Psychopharmacology, March 2017, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  133. The Effectiveness and Safety of Antipsychotic and Antidepressant Medications in Individuals with 22q11.2 Deletion Syndrome

    Article • Journal of Child and Adolescent Psychopharmacology, February 2017, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  134. Insulin delivery to the brain using intracranial implantation of alginate-encapsulated pancreatic islets

    Article • Journal of Tissue Engineering and Regenerative Medicine, January 2017, Wiley

    Dr Konstantin Bloch, Prof ABRAHAM WEIZMAN

  135. Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users

    Article • Current Pharmaceutical Design, January 2017, Bentham Science Publishers

    Professor Aviv Weinstein, Prof ABRAHAM WEIZMAN

  136. Association between Elevated C-Reactive Protein and Manic Polarity in Acute Psychiatric Inpatients with Affective Symptomatology

    Article • Neuropsychobiology, January 2017, Karger Publishers

    Prof ABRAHAM WEIZMAN

  137. Nonfunctional Redundant Acts Characterize OCD, Even in OCD-Unrelated Tasks: A Demonstration in Questionnaire Completion

    Article • Psychopathology, January 2017, Karger Publishers

    Prof ABRAHAM WEIZMAN

  138. A Multimodal Approach For Studying Pathways Leading To Psychosis In 22Q11 Deletion Syndrome

    Article • European Neuropsychopharmacology, January 2017, Elsevier

    Prof ABRAHAM WEIZMAN

  139. Symptoms Versus Impairment in Adults With ADHD: Intercorrelations of the BRIEF-A, CAARS, and TOVA

    Article • Journal of Attention Disorders, December 2016, SAGE Publications

    Prof ABRAHAM WEIZMAN

  140. Predictors of developing mathematics anxiety among middle-school students: A 2-year prospective study

    Article • International Journal of Psychology, December 2016, Wiley

    Prof ABRAHAM WEIZMAN

  141. Antipsychotic adjunctive therapy to mood stabilizers and 1-year rehospitalization rates in bipolar disorder: A cohort study

    Article • Bipolar Disorders, December 2016, Wiley

    Prof ABRAHAM WEIZMAN

  142. Continuous Performance Test Is Sensitive to a Single Methylphenidate Challenge in Preschool Children With ADHD

    Article • Journal of Attention Disorders, November 2016, SAGE Publications

    Prof ABRAHAM WEIZMAN

  143. No Superiority of Treatment With Osmotic Controlled-Release Oral Delivery System–Methylphenidate Over Short/Medium-Acting Methylphenidate Preparations in the Rate and Timing of Injuries in Children With Attention-Deficit/Hyperactivity Disorder

    Article • Clinical Neuropharmacology, November 2016, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  144. Neurocognitive profile in psychotic versus nonpsychotic individuals with 22q11.2 deletion syndrome

    Article • European Neuropsychopharmacology, October 2016, Elsevier

    Prof ABRAHAM WEIZMAN

  145. The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders

    Article • Journal of Child and Adolescent Psychopharmacology, October 2016, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  146. Disturbed DISC1 pathway interacts with adolescent cannabis exposure to produce impaired recognition memory restored by BDNF over-expression: a host-environment mouse model of severe mental illness

    Article • European Neuropsychopharmacology, October 2016, Elsevier

    Prof ABRAHAM WEIZMAN

  147. One-year rehospitalization rates in bipolar disorder manic patients discharged on mood stabilizers versus mood stabilizer combined with antipsychotics

    Article • European Neuropsychopharmacology, October 2016, Elsevier

    Prof ABRAHAM WEIZMAN

  148. The effect of continuous acetylsalicylic acid treatment on exacerbations of psychotic disorders, a retrospective longitudinal study

    Article • European Neuropsychopharmacology, October 2016, Elsevier

    Prof ABRAHAM WEIZMAN

  149. Predictors of short-term outcome variables in hospitalised female adolescents with eating disorders

    Article • International Journal of Psychiatry in Clinical Practice, September 2016, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  150. CD44 Deficiency Is Associated with Increased Susceptibility to Stress-Induced Anxiety-like Behavior in Mice

    Article • Journal of Molecular Neuroscience, September 2016, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  151. Levels of depression and satisfaction with life as indicators of health services consumption

    Article • International Journal of Psychiatry in Clinical Practice, September 2016, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  152. Suicide, Satisfaction With Life, and Insight Capacity Among Adolescents With Mental Disorders

    Article • Crisis, September 2016, Hogrefe Publishing Group

    Prof ABRAHAM WEIZMAN

  153. Association between prematurity and the evolution of psychotic disorders in 22q11.2 deletion syndrome

    Article • Acta Neurovegetativa, August 2016, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  154. Fibre tract analysis using diffusion tensor imaging reveals aberrant connectivity in a rat model of depression

    Article • The World Journal of Biological Psychiatry, July 2016, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  155. Characteristics of Synthetic Cannabinoid and Cannabis Users Admitted to a Psychiatric Hospital

    Article • The Journal of Clinical Psychiatry, July 2016, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  156. Gene polymorphisms potentially related to the pharmacokinetics of clozapine

    Article • International Clinical Psychopharmacology, July 2016, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  157. Psychiatric side effects of acute high-dose corticosteroid therapy in neurological conditions

    Article • International Clinical Psychopharmacology, July 2016, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  158. Pharmacogenetics of citalopram-related side effects in children with depression and/or anxiety disorders

    Article • Acta Neurovegetativa, June 2016, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  159. Trends in the use of antipsychotics in the Israeli inpatient population, 2004–2013

    Article • Israel Journal of Health Policy Research, June 2016, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  160. Cigarette Smoking, Alcohol and Cannabis Use in Patients With Pervasive Developmental Disorders

    Article • Substance Use & Misuse, June 2016, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  161. Do Antidepressants Induce Psychosis in Children and Adolescents? A Naturalistic Study in Ambulatory Pediatric Population

    Article • Journal of Child and Adolescent Psychopharmacology, June 2016, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  162. The clock-drawing test as a possible indicator of acute psychosis

    Article • International Clinical Psychopharmacology, May 2016, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  163. Group cognitive behavioral treatment in female soldiers diagnosed with binge/purge eating disorders

    Article • Eating Disorders, April 2016, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  164. Adherence to Antidepressants Is Associated With Lower Mortality

    Article • The Journal of Clinical Psychiatry, April 2016, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  165. Methadone treatment, bruxism, and temporomandibular disorders among male prisoners

    Article • European Journal Of Oral Sciences, April 2016, Wiley

    Efraim Winocur, Prof ABRAHAM WEIZMAN

  166. The association between serum creatine kinase, mood and psychosis in inpatients with schizophrenia, bipolar and schizoaffective disorders

    Article • Psychiatry Research, April 2016, Elsevier

    Prof ABRAHAM WEIZMAN

  167. CHRNA5/A3/B4Variant rs3743078 and Nicotine-Related Phenotypes: Indirect Effects Through Nicotine Craving

    Article • Journal of Studies on Alcohol and Drugs, March 2016, Alcohol Research Documentation, Inc.

    Prof ABRAHAM WEIZMAN

  168. The CD44 ligand hyaluronic acid is elevated in the cerebrospinal fluid of suicide attempters and is associated with increased blood–brain barrier permeability

    Article • Journal of Affective Disorders, March 2016, Elsevier

    Prof ABRAHAM WEIZMAN

  169. Periodic patterning of the Drosophila eye is stabilized by the diffusible activator Scabrous

    Article • Nature Communications, February 2016, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  170. Elevated C-reactive protein levels in schizophrenia inpatients is associated with aggressive behavior

    Article • European Psychiatry, January 2016, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  171. Seasonal pattern of manic episode admissions among bipolar I disorder patients is associated with male gender and presence of psychotic features

    Article • Journal of Affective Disorders, January 2016, Elsevier

    Prof ABRAHAM WEIZMAN

  172. Treatment of Antipsychotic-Related Akathisia Revisited

    Article • Journal of Clinical Psychopharmacology, December 2015, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  173. Quinazoline-based tricyclic compounds that regulate programmed cell death, induce neuronal differentiation, and are curative in animal models for excitotoxicity and hereditary brain disease

    Article • Cell Death Discovery, November 2015, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  174. Attenuated Weight Gain with the Novel Analog of Olanzapine Linked to Sarcosinyl Moiety (PGW5) Compared to Olanzapine

    Article • Journal of Molecular Neuroscience, November 2015, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  175. Impact of epilepsy and antiepileptic medications on the metabolic profile in adults with autism spectrum disorder and intellectual disabilities

    Article • International Clinical Psychopharmacology, November 2015, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  176. Dehydroepiandrosterone Attenuates Cocaine-Seeking Behaviour Independently of Corticosterone Fluctuations

    Article • Journal of Neuroendocrinology, October 2015, Wiley

    Prof ABRAHAM WEIZMAN

  177. The Association in Elderly Hospitalized Patients, Between Psychotropic Drugs and Hip Fractures Resulting from Falls

    Article • Experimental Aging Research, October 2015, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  178. The association between let-7, RAS and HIF-1α in Ewing Sarcoma tumor growth

    Article • Oncotarget, September 2015, Impact Journals, LLC

    Prof ABRAHAM WEIZMAN

  179. Authors' reply

    Article • The British Journal of Psychiatry, September 2015, Royal College of Psychiatrists

    Prof ABRAHAM WEIZMAN

  180. Effects of long-term valproic acid treatment on hematological and biochemical parameters in adolescent psychiatric inpatients

    Article • International Clinical Psychopharmacology, September 2015, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  181. P.2.d.002 Seasonal pattern of manic episode admissions among bipolar I disorder patients is associated with male gender and higher rates of psychotic features

    Article • European Neuropsychopharmacology, September 2015, Elsevier

    Prof ABRAHAM WEIZMAN

  182. P.3.d.027 The risk for readmission in schizophrenia patients treated with long-acting injectable (typical or atypical) versus oral antipsychotics

    Article • European Neuropsychopharmacology, September 2015, Elsevier

    Prof ABRAHAM WEIZMAN

  183. P.2.b.014 The use of smartphone app for early detection of manic or depressive episodes in affective patients

    Article • European Neuropsychopharmacology, September 2015, Elsevier

    Prof ABRAHAM WEIZMAN

  184. Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder

    Article • Australian & New Zealand Journal of Psychiatry, July 2015, SAGE Publications

    Prof ABRAHAM WEIZMAN

  185. A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: Part II of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder

    Article • Australian & New Zealand Journal of Psychiatry, July 2015, SAGE Publications

    Prof ABRAHAM WEIZMAN

  186. The Impact of Chronic Early Administration of Psychostimulants on Brain Expression of BDNF and Other Neuroplasticity-Relevant Proteins

    Article • Journal of Molecular Neuroscience, July 2015, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  187. The impact of age and gender on adherence to antidepressants: a 4-year population-based cohort study

    Article • Psychopharmacology, June 2015, Springer Science + Business Media

    Dr Moshe B Hoshen, Prof ABRAHAM WEIZMAN

  188. Intracranial pancreatic islet transplantation increases islet hormone expression in the rat brain and attenuates behavioral dysfunctions induced by MK-801 (dizocilpine)

    Article • Hormones and Behavior, June 2015, Elsevier

    Dr Konstantin Bloch, Prof ABRAHAM WEIZMAN

  189. Post-SSRI Sexual Dysfunction

    Article • Journal of Clinical Psychopharmacology, June 2015, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  190. Baclofen as Add-On to Standard Psychosocial Treatment for Alcohol Dependence: a Randomized, Double-Blind, Placebo-Controlled Trial With 1Year Follow-Up

    Article • Journal of Substance Abuse Treatment, May 2015, Elsevier

    Prof ABRAHAM WEIZMAN

  191. Immunomodulatory activity of ketamine in human astroglial A172 cells: Possible relevance to its rapid antidepressant activity

    Article • Journal of Neuroimmunology, May 2015, Elsevier

    Prof ABRAHAM WEIZMAN

  192. High Familial Correlation in Methylphenidate Response and Side Effect Profile

    Article • Journal of Attention Disorders, April 2015, SAGE Publications

    Dr Gal Dubnov-Raz, Prof ABRAHAM WEIZMAN

  193. Alterations in brain neurotrophic and glial factors following early age chronic methylphenidate and cocaine administration

    Article • Behavioural Brain Research, April 2015, Elsevier

    Prof ABRAHAM WEIZMAN

  194. Cognitive Decline Preceding the Onset of Psychosis in Patients With 22q11.2 Deletion Syndrome

    Article • JAMA Psychiatry, April 2015, American Medical Association (AMA)

    Prof ABRAHAM WEIZMAN, Dr. Carrie E Bearden

  195. Effect of dehydroepiandrosterone add-on therapy on mood, decision making and subsequent relapse of polydrug users

    Article • Addiction Biology, March 2015, Wiley

    Prof ABRAHAM WEIZMAN

  196. Adherence to antidepressant therapy and mortality rates in ischaemic heart disease: cohort study

    Article • The British Journal of Psychiatry, February 2015, Royal College of Psychiatrists

    Dr Moshe B Hoshen, Prof ABRAHAM WEIZMAN

  197. The complex Impact of Five Years of Stress Related to Life-Threatening Events on Pregnancy Outcomes: A Preliminary Retrospective Study

    Article • European Psychiatry, February 2015, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  198. SSRI-Induced Activation Syndrome in Children and Adolescents—What Is Next?

    Article • Current Treatment Options in Psychiatry, January 2015, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  199. Hyperactive auditory processing in Williams syndrome: Evidence from auditory evoked potentials

    Article • Psychophysiology, January 2015, Wiley

    Prof ABRAHAM WEIZMAN

  200. Thymic and bone marrow output in individuals with 22q11.2 deletion syndrome

    Article • Pediatric Research, January 2015, Nature

    Dr Gal Dubnov-Raz, Prof ABRAHAM WEIZMAN

  201. Effect of Clozapine and Other Antipsychotics on the Level of Platelet-Associated Autoantibodies in Children with Schizophrenia: A Longitudinal Follow-Up Study

    Article • Neuropsychobiology, January 2015, Karger Publishers

    Prof ABRAHAM WEIZMAN

  202. Pharmacological and behavioral management of some often-overlooked clozapine-induced side effects

    Article • International Clinical Psychopharmacology, November 2014, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  203. Short-Term Effects of Lithium on White Blood Cell Counts and on Levels of Serum Thyroid-Stimulating Hormone and Creatinine in Adolescent Inpatients: A Retrospective Naturalistic Study

    Article • Journal of Child and Adolescent Psychopharmacology, November 2014, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  204. International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder

    Article • Bipolar Disorders, October 2014, Wiley

    Prof ABRAHAM WEIZMAN

  205. Opposing Effects of Oxytocin on Overt Compliance and Lasting Changes to Memory

    Article • Neuropsychopharmacology, October 2014, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  206. Abstract A76: Ras pathway and HIF-1α contribute to the aggressiveness of Ewing sarcoma

    Article • October 2014, American Association for Cancer Research (AACR)

    Prof ABRAHAM WEIZMAN

  207. P.2.h.003 Religiosity decreases self-injurious thoughts and behaviours in Jewish adolescents: findings from a nationally representative survey

    Article • European Neuropsychopharmacology, October 2014, Elsevier

    Dr Moshe B Hoshen, Prof ABRAHAM WEIZMAN

  208. Religiosity is a protective factor against self-injurious thoughts and behaviors in Jewish adolescents: Findings from a nationally representative survey

    Article • European Psychiatry, October 2014, Elsevier

    Dr Moshe B Hoshen, Prof ABRAHAM WEIZMAN

  209. The Beneficial Effect of Trazodone Treatment on Escitalopram-Associated Nocturnal Bruxism

    Article • Journal of Clinical Psychopharmacology, October 2014, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  210. Intrusive trauma recollections is associated with impairment of interference inhibition and psychomotor speed in PTSD

    Article • Comprehensive Psychiatry, October 2014, Elsevier

    Prof ABRAHAM WEIZMAN

  211. P.2.d.004 Association between bipolar episodes and fluid and electrolyte homeostasis: a retrospective longitudinal study

    Article • European Neuropsychopharmacology, October 2014, Elsevier

    Prof ABRAHAM WEIZMAN

  212. P.1.a.006 Decreased A-to-I RNA editing levels in the brains of schizophrenia patients: a possible biomarker

    Article • European Neuropsychopharmacology, October 2014, Elsevier

    Prof ABRAHAM WEIZMAN

  213. Bruxism and oral parafunctional hyperactivity in social phobia outpatients

    Article • Journal of Oral Rehabilitation, September 2014, Wiley

    Efraim Winocur, Prof ABRAHAM WEIZMAN

  214. Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects

    Article • Journal of Psychiatric Research, September 2014, Elsevier

    Prof ABRAHAM WEIZMAN

  215. Beneficial effect of low-dose mirtazapine in acute aripiprazole-induced akathisia

    Article • International Clinical Psychopharmacology, September 2014, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  216. Metabolic profiles in adults with autism spectrum disorder and intellectual disabilities

    Article • European Psychiatry, September 2014, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  217. Parental Alcohol History Differentially Predicts Offspring Disorders in Distinct Subgroups in Israel

    Article • Journal of Studies on Alcohol and Drugs, September 2014, Alcohol Research Documentation, Inc.

    Prof ABRAHAM WEIZMAN

  218. The beneficial effect of escitalopram on obsessive–compulsive-related musical hallucinations in elderly patients with hearing impairment

    Article • International Clinical Psychopharmacology, September 2014, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  219. The beneficial effect of methylphenidate in ADHD with comorbid separation anxiety

    Article • International Clinical Psychopharmacology, September 2014, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  220. Association between bipolar episodes and fluid and electrolyte homeostasis: a retrospective longitudinal study

    Article • Bipolar Disorders, August 2014, Wiley

    Prof ABRAHAM WEIZMAN

  221. Parental psychopathology moderates the influence of parental divorce on lifetime alcohol use disorders among Israeli adults

    Article • Drug and Alcohol Dependence, August 2014, Elsevier

    Prof ABRAHAM WEIZMAN

  222. Effects of the Anti-Multiple Sclerosis Immunomodulator Laquinimod on Anxiety and Depression in Rodent Behavioral Models

    Article • Journal of Molecular Neuroscience, July 2014, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  223. Alcohol Consumption Mediates the Relationship BetweenADH1Band DSM-IV Alcohol Use Disorder and Criteria

    Article • Journal of Studies on Alcohol and Drugs, July 2014, Alcohol Research Documentation, Inc.

    Prof ABRAHAM WEIZMAN

  224. Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia

    Article • International Clinical Psychopharmacology, July 2014, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  225. Psychiatric Disorders From Childhood to Adulthood in 22q11.2 Deletion Syndrome: Results From the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome

    Article • American Journal of Psychiatry, June 2014, American Psychiatric Association

    Mr Laurens JM Evers, Prof ABRAHAM WEIZMAN, Dr. Carrie E Bearden

  226. Corrigendum to ‘Exposure to the Lebanon War of 2006 and effects on alcohol use disorders: The moderating role of childhood maltreatment’ [Drug Alcohol Depend. 134 (2014) 296–303]

    Article • Drug and Alcohol Dependence, June 2014, Elsevier

    Prof ABRAHAM WEIZMAN

  227. Adherence to antidepressants is associated with lower mortality: A four-year population-based cohort study

    Article • Value in Health, May 2014, Elsevier

    Dr Moshe B Hoshen, Prof ABRAHAM WEIZMAN

  228. A comparative study of the neuropsychiatric and neurocognitive phenotype in two microdeletion syndromes: Velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes

    Article • European Psychiatry, May 2014, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  229. Metabolic Effects of Antipsychotics in Prepubertal Children: A Retrospective Chart Review

    Article • Journal of Child and Adolescent Psychopharmacology, May 2014, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  230. Trauma exposure, posttraumatic stress disorder and risk for alcohol, nicotine, and marijuana dependence in Israel

    Article • Comprehensive Psychiatry, April 2014, Elsevier

    Prof ABRAHAM WEIZMAN

  231. Poster #S25 ABERRANT A-I RNA EDITING PROFILE IN THE BRAINS OF SCHIZOPHRENIA PATIENTS

    Article • Schizophrenia Research, April 2014, Elsevier

    Prof ABRAHAM WEIZMAN

  232. A novel analog of olanzapine linked to sarcosinyl moiety (PGW5) demonstrates high efficacy and good safety profile in mouse models of schizophrenia

    Article • European Neuropsychopharmacology, March 2014, Elsevier

    Prof ABRAHAM WEIZMAN

  233. Biological Effects of COMT Haplotypes and Psychosis Risk in 22q11.2 Deletion Syndrome

    Article • Biological Psychiatry, March 2014, Elsevier

    Prof ABRAHAM WEIZMAN

  234. Working memory dysfunction in schizophrenia patients with obsessive-compulsive symptoms: An fMRI study

    Article • European Psychiatry, March 2014, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  235. In vitro effect of FGIN-1-27, a ligand to 18 kDa mitochondrial translocator protein, in human osteoblast-like cells

    Article • Journal of Bioenergetics and Biomembranes, February 2014, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  236. Shyness discriminates between children with 22q11.2 deletion syndrome and Williams syndrome and predicts emergence of psychosis in 22q11.2 deletion syndrome

    Article • Journal of Neurodevelopmental Disorders, February 2014, Springer Science + Business Media

    Professor Ariel Knafo-Noam, Prof ABRAHAM WEIZMAN

  237. Cognitive traits in inpatient adolescents with and without prior suicide attempts and non-suicidal self-injury

    Article • Comprehensive Psychiatry, February 2014, Elsevier

    Prof ABRAHAM WEIZMAN

  238. The effect of endothelial cells on hESC-derived pancreatic progenitors in a 3D environment

    Article • Biomaterials Science, January 2014, Royal Society of Chemistry

    Prof ABRAHAM WEIZMAN

  239. Exposure to the Lebanon War of 2006 and effects on alcohol use disorders: The moderating role of childhood maltreatment

    Article • Drug and Alcohol Dependence, January 2014, Elsevier

    Prof ABRAHAM WEIZMAN

  240. Acute manic episode is associated with an increased risk of lower limb edema

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, December 2013, Elsevier

    Prof ABRAHAM WEIZMAN

  241. Dominant negative DISC1 mutant mice display specific social behaviour deficits and aberration in BDNF and cannabinoid receptor expression

    Article • The World Journal of Biological Psychiatry, November 2013, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  242. Interactions between risky decisions, impulsiveness and smoking in young tattooed women

    Article • BMC Psychiatry, November 2013, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  243. Risk Factors and the Evolution of Psychosis in 22q11.2 Deletion Syndrome: A Longitudinal 2-Site Study

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, November 2013, Elsevier

    Prof ABRAHAM WEIZMAN

  244. Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes

    Article • Journal of Psychiatric Research, November 2013, Elsevier

    Prof ABRAHAM WEIZMAN

  245. miR-192 Directly Binds and Regulates Dicer1 Expression in Neuroblastoma

    Article • PLoS ONE, November 2013, PLOS

    Prof ABRAHAM WEIZMAN

  246. Childhood adversity moderates the effect ofADH1Bon risk for alcohol-related phenotypes in Jewish Israeli drinkers

    Article • Addiction Biology, October 2013, Wiley

    Prof ABRAHAM WEIZMAN

  247. Alcohol Dependence and Suicide-Related Ideation/Behaviors in an Israeli Household Sample, With and Without Major Depression

    Article • Alcoholism Clinical and Experimental Research, October 2013, Wiley

    Prof ABRAHAM WEIZMAN

  248. Hematological and Cardiometabolic Safety of Clozapine in the Treatment of Very Early Onset Schizophrenia: A Retrospective Chart Review

    Article • Journal of Child and Adolescent Psychopharmacology, October 2013, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  249. Gender differences in emotional and behavioral disorders and service use among adolescent smokers: A nationwide Israeli study

    Article • European Psychiatry, September 2013, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  250. Mesenchymal stem cells protect from sub-chronic phencyclidine insult in vivo and counteract changes in astrocyte gene expression in vitro

    Article • European Neuropsychopharmacology, September 2013, Elsevier

    Prof ABRAHAM WEIZMAN

  251. Executive attention deficits in schizophrenia: Putative mandatory and differential cognitive pathology domains in medicated schizophrenia patients

    Article • Psychiatry Research, August 2013, Elsevier

    Prof ABRAHAM WEIZMAN

  252. Neuroprotective and procognitive effects of sertraline: In vitro and in vivo studies

    Article • Neuroscience Letters, August 2013, Elsevier

    Prof ABRAHAM WEIZMAN

  253. Safety of phosphatidylserine containing omega3 fatty acids in ADHD children: A double-blind placebo-controlled trial followed by an open-label extension

    Article • European Psychiatry, August 2013, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  254. The interaction of subjective experience and attitudes towards specific antipsychotic-related adverse effects in schizophrenia patients

    Article • European Psychiatry, August 2013, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  255. Alcohol-Metabolizing Genes and Alcohol Phenotypes in an Israeli Household Sample

    Article • Alcoholism Clinical and Experimental Research, July 2013, Wiley

    Prof ABRAHAM WEIZMAN

  256. Association between a common CYP17A1 haplotype and anxiety in female anorexia nervosa

    Article • Archives of Women s Mental Health, June 2013, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  257. The use of mental health services by adolescent smokers: A nationwide Israeli study

    Article • European Psychiatry, June 2013, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  258. Erratum to "Adherence to antipsychotic drug treatment in early-episode schizophrenia: A six- month naturalistic follow-up study” [Schizophrenia Research, 130 (2011), 176-181]

    Article • Schizophrenia Research, May 2013, Elsevier

    Prof ABRAHAM WEIZMAN

  259. Enhanced Maternal Origin of the 22q11.2 Deletion in Velocardiofacial and DiGeorge Syndromes

    Article • The American Journal of Human Genetics, April 2013, Elsevier

    Prof ABRAHAM WEIZMAN, Dr. Carrie E Bearden

  260. Neonatal stress modulates sickness behavior: Role for proinflammatory cytokines

    Article • Journal of Neuroimmunology, April 2013, Elsevier

    Prof ABRAHAM WEIZMAN

  261. In vitro catabolic effect of protoporphyrin IX in human osteoblast-like cells: possible role of the 18 kDa mitochondrial translocator protein

    Article • Journal of Bioenergetics and Biomembranes, March 2013, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  262. Additive Effects of 5-HTTLPR (Serotonin Transporter) and Tryptophan Hydroxylase 2 G-703T Gene Polymorphisms on the Clinical Response to Citalopram among Children and Adolescents with Depression and Anxiety Disorders

    Article • Journal of Child and Adolescent Psychopharmacology, March 2013, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  263. Enhanced Maternal Origin of the 22q11.2 Deletion in Velocardiofacial and DiGeorge Syndromes

    Article • The American Journal of Human Genetics, March 2013, Elsevier

    Prof ABRAHAM WEIZMAN, Dr. Carrie E Bearden

  264. Escitalopram in the treatment of patients with schizophrenia and obsessive–compulsive disorder

    Article • International Clinical Psychopharmacology, March 2013, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  265. Suicidal Thoughts Are Associated with Platelet Counts in Adolescent Inpatients

    Article • Journal of Child and Adolescent Psychopharmacology, February 2013, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  266. Validity of proposed DSM-5 diagnostic criteria for nicotine use disorder: results from 734 Israeli lifetime smokers

    Article • Psychological Medicine, January 2013, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  267. Mental disorders in primary care in Israel: prevalence and risk factors

    Article • Social Psychiatry and Psychiatric Epidemiology, January 2013, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  268. Attention-Deficit/Hyperactivity Disorder and Comorbid Subsyndromal Depression

    Article • Clinical Neuropharmacology, January 2013, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  269. High Circulatory Titer of Platelet-Associated Autoantibodies in Childhood Onset Schizophrenia and Its Diagnostic Implications

    Article • Neuropsychobiology, January 2013, Karger Publishers

    Prof ABRAHAM WEIZMAN

  270. Reboxetine Treatment for Autistic Spectrum Disorder of Pediatric Patients With Depressive and Inattentive/Hyperactive Symptoms

    Article • Clinical Neuropharmacology, January 2013, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  271. A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy, Safety, and Tolerability of Extended-Release Metadoxine in Adults With Attention-Deficit/Hyperactivity Disorder

    Article • The Journal of Clinical Psychiatry, December 2012, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  272. Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine–betahistine combination

    Article • Psychopharmacology, December 2012, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  273. Genotype-phenotype correlation in 22q11.2 deletion syndrome

    Article • BMC Medical Genetics, December 2012, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  274. Alcohol Use Disorders and Perceived Drinking Norms: Ethnic Differences in Israeli Adults

    Article • Journal of Studies on Alcohol and Drugs, November 2012, Alcohol Research Documentation, Inc.

    Prof ABRAHAM WEIZMAN

  275. Outcomes of compulsorily admitted schizophrenia patients who agreed or disagreed to prolong their hospitalization

    Article • Comprehensive Psychiatry, October 2012, Elsevier

    Prof ABRAHAM WEIZMAN

  276. Rate of readmission and mortality risks of schizophrenia patients who were discharged against medical advice

    Article • European Psychiatry, October 2012, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  277. S.26.03 Metadoxine: a novel non-stimulant extended-release drug for treating ADHD

    Article • European Neuropsychopharmacology, October 2012, Elsevier

    Prof ABRAHAM WEIZMAN

  278. The Effects of Reboxetine Treatment on Depression-like Behavior, Brain Neurotrophins, and ERK Expression in Rats Exposed to Chronic Mild Stress

    Article • Journal of Molecular Neuroscience, September 2012, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  279. Olfactory function and alternation learning in eating disorders

    Article • European Neuropsychopharmacology, September 2012, Elsevier

    Prof ABRAHAM WEIZMAN

  280. Handshaking as a measure of social responsiveness in patients with autistic spectrum disorder

    Article • Comprehensive Psychiatry, August 2012, Elsevier

    Prof ABRAHAM WEIZMAN

  281. Perfectionism, narcissism, and depression in suicidal and nonsuicidal adolescent inpatients

    Article • Comprehensive Psychiatry, August 2012, Elsevier

    Prof ABRAHAM WEIZMAN

  282. Emerging Association Between Addictive Gaming and Attention-Deficit/Hyperactivity Disorder

    Article • Current Psychiatry Reports, July 2012, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  283. Obsessive-compulsive symptoms in schizophrenia: implications for future psychiatric classifications

    Article • Comprehensive Psychiatry, July 2012, Elsevier

    Prof ABRAHAM WEIZMAN

  284. Low self-awareness of ADHD in adults using a self-report screening questionnaire

    Article • European Psychiatry, July 2012, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  285. The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: A double-blind placebo-controlled trial, followed by an open-label extension

    Article • European Psychiatry, July 2012, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  286. The influence of DHEA pretreatment on prepulse inhibition and the HPA-axis stress response in rat offspring exposed prenatally to polyriboinosinic–polyribocytidylic-acid (PIC)

    Article • Neuroscience Letters, July 2012, Elsevier

    Prof ABRAHAM WEIZMAN

  287. The feasibility and safety of S-adenosyl-l-methionine (SAMe) for the treatment of neuropsychiatric symptoms in 22q11.2 deletion syndrome: a double-blind placebo-controlled trial

    Article • Acta Neurovegetativa, June 2012, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  288. Age-of-onset of schizophrenic and obsessive-compulsive symptoms in patients with schizo-obsessive disorder

    Article • Psychiatry Research, May 2012, Elsevier

    Prof ABRAHAM WEIZMAN

  289. Antipsychotic monotherapy and adjuvant psychotropic therapies in schizophrenia patients

    Article • International Clinical Psychopharmacology, May 2012, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  290. Can Minnesota Multiphasic Personality Inventory-2 predict response to selective serotonin reuptake inhibitors in depressed outpatients?

    Article • International Clinical Psychopharmacology, May 2012, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  291. Theory of mind, severity of autistic symptoms and parental correlates in children and adolescents with Asperger syndrome

    Article • Psychiatry Research, May 2012, Elsevier

    Prof ABRAHAM WEIZMAN

  292. Self versus maternal reports of emotional and behavioral difficulties in suicidal and non-suicidal adolescents: An Israeli nationwide survey

    Article • European Psychiatry, April 2012, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  293. Association between tobacco smoking and bipolar affective disorder: clinical, epidemiological, cross-sectional, retrospective study in outpatients

    Article • Comprehensive Psychiatry, April 2012, Elsevier

    Professor Anatoly Kreinin, Prof ABRAHAM WEIZMAN

  294. The Factors Influencing Decision Making on Children’s Psychiatric Hospitalization: A Retrospective Chart Review

    Article • Community Mental Health Journal, February 2012, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  295. Immunomodulatory Effect of Sertraline in a Rat Model of Rheumatoid Arthritis

    Article • NeuroImmunoModulation, January 2012, Karger Publishers

    Prof ABRAHAM WEIZMAN

  296. Antidepressant Treatment for Acute Bipolar Depression: An Update

    Article • Depression Research and Treatment, January 2012, Hindawi Publishing Corporation

    Prof ABRAHAM WEIZMAN

  297. Are Names of Children with Attention Deficit Hyperactivity Disorder More ‘Hyperactive’

    Article • Psychopathology, January 2012, Karger Publishers

    Prof ABRAHAM WEIZMAN

  298. Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs

    Article • Journal of Affective Disorders, January 2012, Elsevier

    Prof ABRAHAM WEIZMAN

  299. Rivastigmine Treatment for the Prevention of Electroconvulsive Therapy–Induced Memory Deficits in Patients With Schizophrenia

    Article • Clinical Neuropharmacology, January 2012, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  300. Late potentials in the signal-averaged electrocardiogram in pre-pubertal children with ADHD, before and after methylphenidate treatment

    Article • European Child & Adolescent Psychiatry, December 2011, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  301. Intracerebral adult stem cells transplantation increases brain-derived neurotrophic factor levels and protects against phencyclidine-induced social deficit in mice

    Article • Translational Psychiatry, December 2011, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  302. Methadone maintenance and cancer risk: An Israeli case registry study

    Article • Drug and Alcohol Dependence, December 2011, Elsevier

    Prof ABRAHAM WEIZMAN

  303. The Effect of Methylphenidate on Prefrontal Cognitive Functioning, Inattention, and Hyperactivity in Velocardiofacial Syndrome

    Article • Journal of Child and Adolescent Psychopharmacology, December 2011, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  304. In vitro mitochondrial effects of PK 11195, a synthetic translocator protein 18 kDa (TSPO) ligand, in human osteoblast-like cells

    Article • Journal of Bioenergetics and Biomembranes, November 2011, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  305. Peptide-binding GRP78 protects neurons from hypoxia-induced apoptosis

    Article • APOPTOSIS, November 2011, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  306. Phenotypic psychiatric characterization of children with Williams syndrome and response of those with ADHD to methylphenidate treatment

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, November 2011, Wiley

    Prof ABRAHAM WEIZMAN

  307. Parental bonding in severely suicidal adolescent inpatients

    Article • European Psychiatry, November 2011, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  308. Predictors of clozapine discontinuation in patients with schizophrenia

    Article • International Clinical Psychopharmacology, November 2011, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  309. Effectiveness and Safety of Citalopram in Hospitalized Adolescents With Major Depression

    Article • Clinical Neuropharmacology, October 2011, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  310. Nicotine dependence, abuse and craving: dimensionality in an Israeli sample

    Article • Addiction, August 2011, Wiley

    Prof ABRAHAM WEIZMAN

  311. Adherence to antipsychotic drug treatment in early-episode schizophrenia: A six-month naturalistic follow-up study

    Article • Schizophrenia Research, August 2011, Elsevier

    Prof ABRAHAM WEIZMAN

  312. Platelet Vesicular Monoamine Transporter 2 Density in the Disruptive Behavior Disorders

    Article • Journal of Child and Adolescent Psychopharmacology, August 2011, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  313. Gonadal steroids and affective symptoms during in vitro fertilization: Implication for reproductive mood disorders

    Article • Psychoneuroendocrinology, July 2011, Elsevier

    Prof ABRAHAM WEIZMAN

  314. Serum Levels of Brain-Derived Neurotrophic Factor and Cortisol to Sulfate of Dehydroepiandrosterone Molar Ratio Associated With Clinical Response to l-Theanine as Augmentation of Antipsychotic Therapy in Schizophrenia and Schizoaffective Disorder Patients

    Article • Clinical Neuropharmacology, July 2011, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  315. When Does It End? Attention-Deficit/Hyperactivity Disorder in the Middle Aged and Older Populations

    Article • Clinical Neuropharmacology, July 2011, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  316. Level of Function at Discharge as a Predictor of Readmission Among Inpatients With Schizophrenia

    Article • American Journal of Occupational Therapy, May 2011, AOTA Press

    Prof ABRAHAM WEIZMAN

  317. Methylphenidate Treatment in Pediatric Patients With Attention-Deficit/Hyperactivity Disorder and Comorbid Trichotillomania

    Article • Clinical Neuropharmacology, May 2011, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  318. Trends in prescribing of psychotropic medications for inpatient adolescents in Israel: A 10 years retrospective analysis

    Article • European Psychiatry, May 2011, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  319. Altered affinity of the platelet vesicular monoamine transporter 2 to dihydrotetrabenazine in children with major depression

    Article • Acta Neurovegetativa, April 2011, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  320. The Effects of Fluoxetine Treatment in a Chronic Mild Stress Rat Model on Depression-Related Behavior, Brain Neurotrophins and ERK Expression

    Article • Journal of Molecular Neuroscience, April 2011, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  321. Cognitive Behavior Therapy for Social Phobia in Large Groups

    Article • International Journal of Cognitive Therapy, March 2011, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  322. Evaluation of Side Effects using the BARS, SAS and AIMS in Pediatric Psychopharmacologic Studies

    Article • European Psychiatry, March 2011, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  323. Level of training of nursing staff and the autonomy given to psychiatric inpatients: a multicenter study

    Article • International Journal of Adolescent Medicine and Health, March 2011, De Gruyter

    Prof ABRAHAM WEIZMAN

  324. The usage of new antipsychotics in treatment of schizophrenia with obsessive-compulsive symptoms

    Article • European Psychiatry, March 2011, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  325. Mirtazapine – A Multifunctional Drug: Low Dose for Akathisia

    Article • CNS Spectrums, February 2011, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  326. GnRH-agonist induced depressive and anxiety symptoms during in vitro fertilization–embryo transfer cycles

    Article • Fertility and Sterility, January 2011, Elsevier

    Prof ABRAHAM WEIZMAN

  327. Low-Dose Quetiapine for Adolescents With Autistic Spectrum Disorder and Aggressive Behavior

    Article • Clinical Neuropharmacology, January 2011, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  328. The Immunomodulatory Effect of the Antidepressant Sertraline in an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis

    Article • NeuroImmunoModulation, January 2011, Karger Publishers

    Prof ABRAHAM WEIZMAN

  329. Schizophrenia Spectrum Disorders and Risk for Cancer Morbidity and Mortality

    Article • January 2011, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  330. The role of dehydroepiandrosterone (DHEA) in drug-seeking behavior

    Article • Neuroscience & Biobehavioral Reviews, November 2010, Elsevier

    Prof ABRAHAM WEIZMAN

  331. The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHD

    Article • European Neuropsychopharmacology, October 2010, Elsevier

    Prof ABRAHAM WEIZMAN

  332. Association of polymorphisms of the serotonergic pathways with clinical traits of impulsive-aggression and suicidality in adolescents: A multi-center study

    Article • The World Journal of Biological Psychiatry, September 2010, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  333. Monitoring of Circadian Rhythms of Heart Rate, Locomotor Activity, and Temperature for Diagnosis and Evaluation of Response to Treatment in an Animal Model of Depression

    Article • Journal of Molecular Neuroscience, September 2010, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  334. Trazodone for the Treatment of Neuroleptic-Induced Acute Akathisia

    Article • Clinical Neuropharmacology, September 2010, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  335. In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells

    Article • International Journal of Oncology, September 2010, Spandidos Publications

    Prof ABRAHAM WEIZMAN

  336. S.03.04 An alternative approach to antipsychotic activity: the metabotropic glutamatergic receptor

    Article • European Neuropsychopharmacology, August 2010, Elsevier

    Prof ABRAHAM WEIZMAN

  337. Alterations in QT dispersion in the surface electrocardiogram of female adolescent inpatients diagnosed with bulimia nervosa

    Article • Comprehensive Psychiatry, July 2010, Elsevier

    Prof ABRAHAM WEIZMAN

  338. Pregnenolone and Dehydroepiandrosterone as an Adjunctive Treatment in Schizophrenia and Schizoaffective Disorder

    Article • The Journal of Clinical Psychiatry, June 2010, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  339. Lack of modulatory effect of short-term repeated electroconvulsive therapy on platelet vesicular monoamine transporter 2 (VMAT2) in depressed patients

    Article • Acta Neurovegetativa, June 2010, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  340. Fear Thou Not: Activity of Frontal and Temporal Circuits in Moments of Real-Life Courage

    Article • Neuron, June 2010, Elsevier

    Prof ABRAHAM WEIZMAN

  341. A Review of: “The Oxford Textbook of Suicidology and Suicide Prevention: A Global Perspective”

    Article • Archives of Suicide Research, April 2010, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  342. Possible association between attention deficit hyperactivity disorder and attempted suicide in adolescents – A pilot study

    Article • European Psychiatry, April 2010, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  343. Stroop performance in major depression: Selective attention impairment or psychomotor slowness?

    Article • Journal of Affective Disorders, April 2010, Elsevier

    Prof ABRAHAM WEIZMAN

  344. WORKING MEMORY IMPAIRMENTS IN SCHIZOPHRENIA AS VALID PREDICTORS OF ILNESS SEVERITY AND FUNCTIONAL OUTCOME

    Article • Schizophrenia Research, April 2010, Elsevier

    Prof ABRAHAM WEIZMAN

  345. Alteration learning in social anxiety disorder: An fMRI study

    Article • The World Journal of Biological Psychiatry, March 2010, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  346. Late potentials in the signal-averaged electrocardiogram in schizophrenia patients maintained on antipsychotic agents

    Article • European Neuropsychopharmacology, March 2010, Elsevier

    Prof ABRAHAM WEIZMAN

  347. Microstructural evolution during the infiltration of boron carbide with molten silicon

    Article • Journal of the European Ceramic Society, March 2010, Elsevier

    Prof ABRAHAM WEIZMAN, Professor Shmuel Hayun

  348. Stability of Schizoaffective Disorder in Correlation with Duration of Follow-Up: Retrospective Analysis

    Article • Psychopathology, January 2010, Karger Publishers

    Prof ABRAHAM WEIZMAN

  349. Early Repolarization in Young Children with Attention-Deficit/Hyperactivity Disorder Versus Normal Controls: A Retrospective Preliminary Chart Review Study

    Article • Journal of Child and Adolescent Psychopharmacology, December 2009, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  350. Psychiatric Disorders and Intellectual Functioning Throughout Development in Velocardiofacial (22q11.2 Deletion) Syndrome

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, November 2009, Elsevier

    Prof ABRAHAM WEIZMAN

  351. Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study

    Article • Acta Neurovegetativa, October 2009, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  352. Platelet poor plasma serotonin level in delinquent adolescents diagnosed with conduct disorder

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, October 2009, Elsevier

    Prof ABRAHAM WEIZMAN

  353. Proapoptotic and chemosensitizing effects of selective serotonin reuptake inhibitors on T cell lymphoma/leukemia (Jurkat) in vitro

    Article • European Neuropsychopharmacology, October 2009, Elsevier

    Prof ABRAHAM WEIZMAN

  354. Personality characteristics and gonadal steroid manipulation in IVF treatments: predictors of successful outcome

    Article • Fertility and Sterility, September 2009, Elsevier

    Prof ABRAHAM WEIZMAN

  355. Association between corneal temperature and mental status of treatment-resistant schizophrenia inpatients

    Article • European Neuropsychopharmacology, September 2009, Elsevier

    Prof ABRAHAM WEIZMAN

  356. β-Adrenergic Antagonists for the Treatment of Clozapine-Induced Sinus Tachycardia

    Article • Clinical Neuropharmacology, September 2009, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  357. Influence of Methylphenidate Treatment on Smoking Behavior in Adolescent Girls With Attention-Deficit/Hyperactivity and Borderline Personality Disorders

    Article • Clinical Neuropharmacology, September 2009, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  358. P.7.e.002 Pharmacogenetics of acute treatment of depression and anxiety in children and adolescents

    Article • European Neuropsychopharmacology, September 2009, Elsevier

    Prof ABRAHAM WEIZMAN

  359. Attenuation of cue-induced smoking urges and brain reward activity in smokers treated successfully with bupropion

    Article • Journal of Psychopharmacology, July 2009, SAGE Publications

    Prof ABRAHAM WEIZMAN

  360. DHEA and DHEA-S levels in hospitalized adolescents with first-episode schizophrenia and conduct disorder: A comparison study

    Article • European Neuropsychopharmacology, July 2009, Elsevier

    Prof ABRAHAM WEIZMAN

  361. Efficacy of Reboxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder in Boys With Intolerance to Methylphenidate

    Article • Clinical Neuropharmacology, July 2009, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  362. Reduced levels of miR-34a in neuroblastoma are not caused by mutations in theTP53binding site

    Article • Genes Chromosomes and Cancer, July 2009, Wiley

    Prof ABRAHAM WEIZMAN

  363. Zolmitriptan compared to propranolol in the treatment of acute neuroleptic-induced akathisia: A comparative double-blind study

    Article • European Neuropsychopharmacology, July 2009, Elsevier

    Prof ABRAHAM WEIZMAN

  364. The Effect of Particle Size Distribution on the Microstructure and the Mechanical Properties of Boron Carbide-Based Reaction-Bonded Composites

    Article • International Journal of Applied Ceramic Technology, July 2009, Wiley

    Prof ABRAHAM WEIZMAN, Professor Shmuel Hayun

  365. Effect of Implementing Dental Services in Israeli Psychiatric Hospitals on the Oral and Dental Health of Inpatients

    Article • Psychiatric Services, June 2009, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  366. Rim region growth and its composition in reaction bonded boron carbide composites with core-rim structure

    Article • Journal of Physics Conference Series, June 2009, Institute of Physics Publishing

    Prof ABRAHAM WEIZMAN, Professor Shmuel Hayun

  367. γ-Aminobutyric Acid Amides of Nortriptyline and Fluoxetine Display Improved Pain Suppressing Activity

    Article • Journal of Medicinal Chemistry, May 2009, American Chemical Society (ACS)

    Prof ABRAHAM WEIZMAN

  368. An integrative quantitative model of factors influencing the course of anorexia nervosa over time

    Article • International Journal of Eating Disorders, May 2009, Wiley

    Prof ABRAHAM WEIZMAN

  369. Velocardiofacial Syndrome

    Article • Journal of Mental Health Research in Intellectual Disabilities, April 2009, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  370. Priapism as an unusual manifestation of catatonia: A case report

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, April 2009, Elsevier

    Prof ABRAHAM WEIZMAN

  371. The risk for cancer among patients with schizoaffective disorders

    Article • Journal of Affective Disorders, April 2009, Elsevier

    Prof ABRAHAM WEIZMAN

  372. Attention-Deficit Hyperactivity Disorder, Methylphenidate, and Primary Encopresis

    Article • Psychosomatics, March 2009, Elsevier

    Prof ABRAHAM WEIZMAN

  373. Differences in audiovisual integration, as measured by McGurk phenomenon, among adult and adolescent patients with schizophrenia and age-matched healthy control groups

    Article • Comprehensive Psychiatry, March 2009, Elsevier

    Prof ABRAHAM WEIZMAN

  374. Factors Determining Satisfaction in Psychiatry Training in Israel

    Article • Academic Psychiatry, March 2009, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  375. Impact of depression on treatment effectiveness and gains maintenance in social phobia: a naturalistic study of cognitive behavior group therapy

    Article • Depression and Anxiety, March 2009, Wiley

    Prof ABRAHAM WEIZMAN

  376. Neuropsychological mechanisms of Digit Symbol Substitution Test impairment in Asperger Disorder

    Article • Psychiatry Research, March 2009, Elsevier

    Prof ABRAHAM WEIZMAN

  377. Trazodone for the Treatment of Sexual Dysfunction Induced by Serotonin Reuptake Inhibitors

    Article • Clinical Neuropharmacology, March 2009, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  378. P.3.15 Serum creatine kinase levels and neuromuscular dysfunction in psychiatric patients: new results of follow-up study

    Article • European Neuropsychopharmacology, March 2009, Elsevier

    Prof ABRAHAM WEIZMAN

  379. Effect of Exposure to Selective Serotonin Reuptake Inhibitors In Utero on Fetal Growth: Potential Role for the IGF-I and HPA Axes

    Article • Pediatric Research, February 2009, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  380. Serum creatine kinase activity differentiates alcohol syndromes of dependence, withdrawal and delirium tremens

    Article • European Neuropsychopharmacology, February 2009, Elsevier

    Prof ABRAHAM WEIZMAN

  381. BL-1020: A novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia

    Article • European Neuropsychopharmacology, January 2009, Elsevier

    Prof ABRAHAM WEIZMAN

  382. Altered thermoregulation in ambulatory schizophrenia patients: A naturalistic study

    Article • The World Journal of Biological Psychiatry, January 2009, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  383. Blind Verification of Elevated Platelet Autoantibodies in Serum of Schizophrenic Patients – Part I: Young Subjects

    Article • Neuropsychobiology, January 2009, Karger Publishers

    Prof ABRAHAM WEIZMAN

  384. Blind Verification of Elevated Platelet Autoantibodies in Serum of Schizophrenic Patients – Part II: Adult Subjects

    Article • Neuropsychobiology, January 2009, Karger Publishers

    Prof ABRAHAM WEIZMAN

  385. Improvement of aggressive behavior and quality of life impairment following S-Adenosyl-Methionine (SAM-e) augmentation in schizophrenia

    Article • European Neuropsychopharmacology, January 2009, Elsevier

    Prof ABRAHAM WEIZMAN

  386. Monoamines, BDNF, Dehydroepiandrosterone, DHEA-Sulfate, and Childhood Depression—An Animal Model Study

    Article • Advances in Pharmacological Sciences, January 2009, Hindawi Publishing Corporation

    Prof ABRAHAM WEIZMAN

  387. Neurosteroid blood levels in delinquent adolescent boys with conduct disorder

    Article • European Neuropsychopharmacology, January 2009, Elsevier

    Prof ABRAHAM WEIZMAN

  388. Efficacy and Safety of N-3 Phosphatidylserine in Children with Attention Deficit and Hyperactivity Disorder (ADHD)

    Article • European Psychiatry, January 2009, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  389. Methylphenidate Treatment in ADHD/borderline Personality Disorder Adolescent Girls and Smoking Behavior

    Article • European Psychiatry, January 2009, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  390. Schizophrenia Endophenotypes as Treatment Targets

    Article • January 2009, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  391. Neuroprotective effect of Ro5-4864 following brain injury

    Article • Experimental Neurology, December 2008, Elsevier

    Prof ABRAHAM WEIZMAN

  392. A cross-fostering study in a genetic animal model of depression: Maternal behavior and depression-like symptoms

    Article • Pharmacology Biochemistry and Behavior, November 2008, Elsevier

    Prof ABRAHAM WEIZMAN

  393. Pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety

    Article • Pharmacogenomics, November 2008, Future Medicine

    Prof ABRAHAM WEIZMAN

  394. The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line

    Article • Pharmacogenetics and Genomics, November 2008, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  395. Decreased M1 muscarinic receptor density in rat amphetamine model of schizophrenia is normalized by clozapine, but not haloperidol

    Article • Acta Neurovegetativa, September 2008, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  396. Disaster mental health in Asia and the Asian Journal of Psychiatry

    Article • Asian Journal of Psychiatry, September 2008, Elsevier

    Prof ABRAHAM WEIZMAN

  397. Hormonal Response to Dehydroepiandrosterone Administration in Schizophrenia

    Article • Journal of Clinical Psychopharmacology, August 2008, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  398. In vivo occipital–frontal temperature-gradient in schizophrenia patients and its possible association with psychopathology: A magnetic resonance spectroscopy study

    Article • European Neuropsychopharmacology, August 2008, Elsevier

    Prof ABRAHAM WEIZMAN

  399. P.6.c.005 Attenuation of cue-induced cigarette urges and brain activity in bupropion-treated smokers

    Article • European Neuropsychopharmacology, August 2008, Elsevier

    Prof ABRAHAM WEIZMAN

  400. P.1.c.007 Serotonin pathway genes polymorphisms and the clinical response to citalopram among children and adolescents

    Article • European Neuropsychopharmacology, August 2008, Elsevier

    Prof ABRAHAM WEIZMAN

  401. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial

    Article • International Clinical Psychopharmacology, July 2008, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  402. Relationship between antidepressants and IGF-1 system in the brain: Possible role in cognition

    Article • European Neuropsychopharmacology, June 2008, Elsevier

    Prof ABRAHAM WEIZMAN

  403. The effect of DHEA complementary treatment on heroin addicts participating in a rehabilitation program: A preliminary study

    Article • European Neuropsychopharmacology, June 2008, Elsevier

    Prof ABRAHAM WEIZMAN

  404. The possible involvement of metabotropic glutamate receptors in schizophrenia

    Article • European Neuropsychopharmacology, June 2008, Elsevier

    Prof ABRAHAM WEIZMAN

  405. DHEA Lessens Depressive-Like Behavior via GABA-ergic Modulation of the Mesolimbic System

    Article • Neuropsychopharmacology, May 2008, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  406. A Mutual Prodrug Ester of GABA and Perphenazine Exhibits Antischizophrenic Efficacy with Diminished Extrapyramidal Effects

    Article • Journal of Medicinal Chemistry, May 2008, American Chemical Society (ACS)

    Prof ABRAHAM WEIZMAN

  407. Enhanced cancer risk among patients with bipolar disorder

    Article • Journal of Affective Disorders, May 2008, Elsevier

    Prof ABRAHAM WEIZMAN

  408. Sense of coherence among delusional patients: prediction of remission and risk of relapse

    Article • Comprehensive Psychiatry, May 2008, Elsevier

    Prof ABRAHAM WEIZMAN

  409. Dehydroepiandrosterone and monoamines in the limbic system of a genetic animal model of childhood depression

    Article • European Neuropsychopharmacology, April 2008, Elsevier

    Prof ABRAHAM WEIZMAN

  410. Does a Clerkship in Psychiatry Contribute to Changing Medical Students' Attitudes Towards Psychiatry?

    Article • Academic Psychiatry, April 2008, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  411. Evidence for an inhibitory immunomodulatory effect of selected antidepressants on rat splenocytes: Possible relevance to depression and hyperactive-immune disorders

    Article • International Immunopharmacology, April 2008, Elsevier

    Prof ABRAHAM WEIZMAN

  412. Recurrnet catatonia: Fluctuating between psychotic and catatonic dimensions

    Article • European Psychiatry, April 2008, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  413. Aripiprazole’s Receptor Pharmacology and Extrapyramidal Side Effects

    Article • American Journal of Psychiatry, March 2008, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  414. Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: A preliminary study

    Article • European Neuropsychopharmacology, February 2008, Elsevier

    Prof ABRAHAM WEIZMAN

  415. Neuroactive Steroids in Brain Function, Behavior and Neuropsychiatric Disorders

    Article • January 2008, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  416. Itching in the Psychiatric Ward

    Article • Acta Dermato Venereologica, January 2008, Acta Dermato-Venereologica

    Prof ABRAHAM WEIZMAN

  417. Multi-modal weight control intervention for people with persistent mental disorders.

    Article • Psychiatric Rehabilitation Journal, January 2008, American Psychological Association (APA)

    Prof ABRAHAM WEIZMAN

  418. The Impact of Mental Illness on Sexual Dysfunction

    Article • January 2008, Karger Publishers

    Prof ABRAHAM WEIZMAN

  419. The influence of clozapine treatment and other antipsychotics on the 18 kDa translocator protein, formerly named the peripheral-type benzodiazepine receptor, and steroid production

    Article • European Neuropsychopharmacology, January 2008, Elsevier

    Prof ABRAHAM WEIZMAN

  420. Ziprasidone: clinical properties and therapeutic promise

    Article • Future Neurology, January 2008, Future Medicine

    Prof ABRAHAM WEIZMAN

  421. Objective Versus Subjective Assessment of Methylphenidate Response

    Article • Child Psychiatry & Human Development, December 2007, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  422. CK levels in unmedicated bipolar patients

    Article • European Neuropsychopharmacology, December 2007, Elsevier

    Prof ABRAHAM WEIZMAN

  423. Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression

    Article • European Neuropsychopharmacology, December 2007, Elsevier

    Prof ABRAHAM WEIZMAN

  424. Reboxetine Maintenance Treatment in Children with Attention-Deficit/Hyperactivity Disorder: A Long-Term Follow-Up Study

    Article • Journal of Child and Adolescent Psychopharmacology, December 2007, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  425. Serotonin Transporter Polymorphism (5-HTTLPR) and Citalopram Effectiveness and Side Effects in Children with Depression and/or Anxiety Disorders

    Article • Journal of Child and Adolescent Psychopharmacology, December 2007, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  426. Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases

    Article • Molecular and Cellular Neuroscience, November 2007, Elsevier

    Prof ABRAHAM WEIZMAN

  427. Dehydroepiandrosterone in the nucleus accumbens is associated with early onset of depressive-behavior: A study in an animal model of childhood depression

    Article • Neuroscience, November 2007, Elsevier

    Prof ABRAHAM WEIZMAN

  428. Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS

    Article • The International Journal of Neuropsychopharmacology, October 2007, Oxford University Press (OUP)

    Prof ABRAHAM WEIZMAN

  429. Risk of readmission in compulsorily and voluntarily admitted patients

    Article • Social Psychiatry and Psychiatric Epidemiology, August 2007, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  430. Effect of ADH1B Genotype on Alcohol Consumption in Young Israeli Jews

    Article • Alcoholism Clinical and Experimental Research, August 2007, Wiley

    Prof ABRAHAM WEIZMAN

  431. Circulatory neurosteroid levels in smoking and non-smoking chronic schizophrenia patients

    Article • European Neuropsychopharmacology, July 2007, Elsevier

    Prof ABRAHAM WEIZMAN

  432. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone

    Article • International Clinical Psychopharmacology, July 2007, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  433. Reduced platelet vesicular monoamine transporter density in Tourette's syndrome pediatric male patients

    Article • European Neuropsychopharmacology, July 2007, Elsevier

    Prof ABRAHAM WEIZMAN

  434. Cognition, psychosocial adjustment and coping in familial cases of velocardiofacial syndrome

    Article • Acta Neurovegetativa, June 2007, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  435. Sildenafil citrate in the treatment of sexual dysfunction and its effect on quality of life in alcohol dependent men: preliminary findings

    Article • Alcohol and Alcoholism, May 2007, Oxford University Press (OUP)

    Prof ABRAHAM WEIZMAN

  436. A significant correlation between ward temperature and the severity of symptoms in schizophrenia inpatients — A longitudinal study

    Article • European Neuropsychopharmacology, May 2007, Elsevier

    Prof ABRAHAM WEIZMAN

  437. Neurological Soft Signs in Schizophrenia Patients With Obsessive-Compulsive Disorder

    Article • Journal of Neuropsychiatry, May 2007, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  438. Alterations in QT dispersion in the surface electrocardiogram of female adolescents diagnosed with restricting-type anorexia nervosa

    Article • Journal of Psychosomatic Research, April 2007, Elsevier

    Prof ABRAHAM WEIZMAN

  439. Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects

    Article • European Neuropsychopharmacology, April 2007, Elsevier

    Prof ABRAHAM WEIZMAN

  440. Neurological Soft Signs in Schizophrenia Patients With Obsessive-Compulsive Disorder

    Article • Journal of Neuropsychiatry, April 2007, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  441. QT Interval and Dispersion in Very Young Children Treated with Antipsychotic Drugs: A Retrospective Chart Review

    Article • Journal of Child and Adolescent Psychopharmacology, April 2007, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  442. State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients

    Article • European Neuropsychopharmacology, March 2007, Elsevier

    Prof ABRAHAM WEIZMAN

  443. Prolactin and estradiol serum levels in unmedicated male paranoid schizophrenia patients

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, March 2007, Elsevier

    Prof ABRAHAM WEIZMAN

  444. Decreased platelet vesicular monoamine transporter binding capacity in tourette syndrome

    Article • European Psychiatry, March 2007, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  445. Objective versus subjective assessment of MPH response

    Article • European Psychiatry, March 2007, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  446. QT interval and dispersion in very young children treated with antipsychotic drugs

    Article • European Psychiatry, March 2007, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  447. The possible association, in adolescence, between attention deficit and hyperactivity disorder and attempted suicide – a pilot study

    Article • European Psychiatry, March 2007, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  448. Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study

    Article • Psychopharmacology, February 2007, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  449. Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: A randomized, double-blind placebo controlled trial

    Article • Psychoneuroendocrinology, February 2007, Elsevier

    Prof ABRAHAM WEIZMAN

  450. Association of the serotonin transporter promotor polymorphism with suicide attempters with a high medical damage

    Article • European Neuropsychopharmacology, February 2007, Elsevier

    Prof ABRAHAM WEIZMAN

  451. Neurosteroids in child and adolescent psychopathology

    Article • European Neuropsychopharmacology, February 2007, Elsevier

    Prof ABRAHAM WEIZMAN

  452. Serum creatine kinase level in unmedicated nonpsychotic, psychotic, bipolar and schizoaffective depressed patients

    Article • European Neuropsychopharmacology, February 2007, Elsevier

    Prof ABRAHAM WEIZMAN

  453. A 10-year retrospective study of inpatient adolescents with schizophrenia/schizoaffective disorder and substance use

    Article • Comprehensive Psychiatry, January 2007, Elsevier

    Prof ABRAHAM WEIZMAN

  454. Demographic and clinical characteristics of motor vehicle accident victims in the community general health outpatient clinic: a comparison of PTSD and non-PTSD subjects

    Article • Depression and Anxiety, January 2007, Wiley

    Prof ABRAHAM WEIZMAN

  455. Depressed mood through women's reproductive cycle: correlation to mood at menopause

    Article • Climacteric, January 2007, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  456. Dual contribution of NR2B subunit of NMDA receptor and SK3 Ca2+-activated K+ channel to genetic predisposition to anorexia nervosa

    Article • Journal of Psychiatric Research, January 2007, Elsevier

    Prof ABRAHAM WEIZMAN

  457. Psychological and cytokine changes in children and adolescents undergoing hematopoietic stem cell transplantation

    Article • European Neuropsychopharmacology, January 2007, Elsevier

    Prof ABRAHAM WEIZMAN

  458. Serotonin transporter characteristics in lymphocytes and platelets of male aggressive schizophrenia patients compared to non-aggressive schizophrenia patients

    Article • European Neuropsychopharmacology, December 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  459. Aggressive behavior and HPA axis hormones after social isolation in adult rats of two different genetic animal models for depression

    Article • Behavioural Brain Research, December 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  460. Homocysteine levels in adolescent schizophrenia patients

    Article • European Neuropsychopharmacology, December 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  461. Substance Use, Suicidality, and Adolescent-Onset Schizophrenia: An Israeli 10-Year Retrospective Study

    Article • Journal of Child and Adolescent Psychopharmacology, December 2006, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  462. Modulatory Effects of Thyroxine Treatment on Central and Peripheral Benzodiazepine Receptors in the Rat

    Article • Journal of Neurochemistry, October 2006, Wiley

    Prof ABRAHAM WEIZMAN

  463. Electroconvulsive Therapy and Transcranial Magnetic Stimulation: Can They be Considered Valid Modalities in the Treatment of Pediatric Mood Disorders?

    Article • Child and Adolescent Psychiatric Clinics of North America, October 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  464. Preferential Aggregation of Obsessive—Compulsive Spectrum Disorders in Schizophrenia Patients with Obsessive—Compulsive Disorder

    Article • The Canadian Journal of Psychiatry, October 2006, SAGE Publications

    Prof ABRAHAM WEIZMAN

  465. Stress hormones and emotion-regulation in two genetic animal models of depression

    Article • Psychoneuroendocrinology, October 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  466. The protective effect of frontal cortex dehydroepiandrosterone in anxiety and depressive models in mice

    Article • Pharmacology Biochemistry and Behavior, October 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  467. The use of illicit substances in adolescent schizophrenia inpatients

    Article • International Journal of Adolescent Medicine and Health, October 2006, De Gruyter

    Prof ABRAHAM WEIZMAN

  468. Erratum to “Involvement of GABAA receptor modulating neuroactive steroids in patients with social phobia” [Psychiatry Res. 137 (2005) 131–136]

    Article • Psychiatry Research, September 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  469. Cocaine, but not amphetamine, short term treatment elevates the density of rat brain vesicular monoamine transporter 2

    Article • Acta Neurovegetativa, August 2006, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  470. Characterization of the serotonin transporter in lymphocytes and platelets of schizophrenia patients treated with atypical or typical antipsychotics compared to healthy individuals

    Article • European Neuropsychopharmacology, August 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  471. An Open-Label Randomized Comparison of Olanzapine Versus Risperidone in the Treatment of Childhood-Onset Schizophrenia

    Article • Journal of Child and Adolescent Psychopharmacology, August 2006, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  472. Impact of Gastric Banding on Plasma Adiponectin Levels

    Article • Obesity Surgery, August 2006, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  473. Obsessive–compulsive disorder in bipolar disorder patients with first manic episode

    Article • Journal of Affective Disorders, August 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  474. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function

    Article • Trends in Pharmacological Sciences, August 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  475. The Child in the Family of a Drug-Using Father: Attachment Styles and Family Characteristics

    Article • Journal of Social Work Practice in the Addictions, July 2006, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  476. Elevated platelet vesicular monoamine transporter 2 in former heroin addicts maintained on methadone

    Article • Acta Neurovegetativa, July 2006, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  477. Thyroxine-Triiodothyronine Combination TherapyVersusThyroxine Monotherapy for Clinical Hypothyroidism: Meta-Analysis of Randomized Controlled Trials

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2006, Endocrine Society

    Prof ABRAHAM WEIZMAN

  478. Dehydroepiandrosterone (DHEA) attenuates cocaine-seeking behavior in the self-administration model in rats

    Article • European Neuropsychopharmacology, July 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  479. A complete genetic association scan of the 22q11 deletion region and functional evidence reveal an association between DGCR2 and schizophrenia

    Article • Human Genetics, June 2006, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  480. Factors Associated with Self-evaluated Severity of Illness and Quality of Life in Male Israeli Asthmatic Soldiers

    Article • Quality of Life Research, June 2006, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  481. Low-Dose Mirtazapine: A New Option in the Treatment of Antipsychotic-Induced Akathisia. A Randomized, Double-Blind, Placebo- and Propranolol-Controlled Trial

    Article • Biological Psychiatry, June 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  482. Association of the low-activity COMT 158Met allele with ADHD and OCD in subjects with velocardiofacial syndrome

    Article • The International Journal of Neuropsychopharmacology, May 2006, Oxford University Press (OUP)

    Prof ABRAHAM WEIZMAN

  483. The protective activity of brain dehydroepiandrosterone (DHEA) in behavioral disorders

    Article • Frontiers in Neuroendocrinology, May 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  484. Reboxetine Versus Fluvoxamine in the Treatment of Motor Vehicle Accident-related Posttraumatic Stress Disorder

    Article • Journal of Clinical Psychopharmacology, April 2006, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  485. The relevance of neurosteroids to clinical psychiatry: From the laboratory to the bedside

    Article • European Neuropsychopharmacology, April 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  486. Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study

    Article • International Clinical Psychopharmacology, March 2006, Wolters Kluwer Health

    Professor Anatoly Kreinin, Prof ABRAHAM WEIZMAN

  487. Alterations in DHEA metabolism in schizophrenia: Two-month case-control study

    Article • European Neuropsychopharmacology, February 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  488. Effects of early-life stress on behavior and neurosteroid levels in the rat hypothalamus and entorhinal cortex

    Article • Brain Research Bulletin, February 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  489. Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder

    Article • European Neuropsychopharmacology, February 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  490. DHEA, a Neurosteroid, Decreases Cocaine Self-Administration and Reinstatement of Cocaine-Seeking Behavior in Rats

    Article • Neuropsychopharmacology, January 2006, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  491. A Six-Month Outcome of Long-Stay Inpatients Resettled in a Hostel.

    Article • Psychiatric Rehabilitation Journal, January 2006, American Psychological Association (APA)

    Prof ABRAHAM WEIZMAN

  492. Clinical characteristics of inpatient adolescents with severe obsessive–compulsive disorder

    Article • Depression and Anxiety, January 2006, Wiley

    Prof ABRAHAM WEIZMAN

  493. Comparison between risperidone, olanzapine, and clozapine in the management of chronic schizophrenia: a naturalistic prospective 12-week observational study

    Article • Human Psychopharmacology Clinical and Experimental, January 2006, Wiley

    Prof ABRAHAM WEIZMAN

  494. Obstetric complications in individuals diagnosed with autism and in healthy controls

    Article • Comprehensive Psychiatry, January 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  495. Plasma serotonin levels and suicidal behavior in adolescents

    Article • European Neuropsychopharmacology, January 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  496. Serotonin uptake to lymphocytes of patients with social phobia compared to normal individuals

    Article • European Neuropsychopharmacology, January 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  497. Two Different Putative Genetic Animal Models of Childhood Depression

    Article • Biological Psychiatry, January 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  498. P.3.c.022 Amelioration of symptomatology, Parkinsonism and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in schizophrenia

    Article • European Neuropsychopharmacology, January 2006, Elsevier

    Prof ABRAHAM WEIZMAN

  499. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth

    Article • Oncology Reports, January 2006, Spandidos Publications

    Prof ABRAHAM WEIZMAN

  500. The effect of psychostimulants on [3H]dopamine uptake and release in rat brain synaptic vesicles

    Article • Acta Neurovegetativa, December 2005, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  501. Circulatory neurosteroid levels in underweight female adolescent anorexia nervosa inpatients and following weight restoration

    Article • European Neuropsychopharmacology, December 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  502. Life events and suicidality in adolescents with schizophrenia

    Article • European Child & Adolescent Psychiatry, December 2005, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  503. Pilot Study: Fluvoxamine Treatment for Depression and Anxiety Disorders in Children and Adolescents with Cancer

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, December 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  504. Improvement of extrapyramidal symptoms following dehydroepiandrosterone (DHEA) administration in antipsychotic treated schizophrenia patients: A randomized, double-blind placebo controlled trial

    Article • Schizophrenia Research, November 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  505. Haplotype analysis of theCOMT-ARVCFgene region in Israeli anorexia nervosa family trios

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, November 2005, Wiley

    Prof ABRAHAM WEIZMAN

  506. The Relationship between BMI, Plasma Leptin, Insulin and Proinsulin Before and After Laparoscopic Adjustable Gastric Banding

    Article • Obesity Surgery, November 2005, Springer Science + Business Media

    Dr Konstantin Bloch, Prof ABRAHAM WEIZMAN

  507. Memantine for Treatment-Resistant OCD

    Article • American Journal of Psychiatry, November 2005, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  508. Hormonal Profile Effects Following Dehydroepiandrosterone (DHEA) Administration to Schizophrenic Patients

    Article • Clinical Neuropharmacology, November 2005, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  509. Involvement of GABAA receptor modulating neuroactive steroids in patients with social phobia

    Article • Psychiatry Research, November 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  510. Involvement of prostaglandins in an animal model of Shigella-related seizures

    Article • Journal of Neuroimmunology, November 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  511. Erratum to “Cancer in schizophrenia: Is the risk higher or lower?” [Schizophr. Res. 2005 Mar 1;73(2–3):333–41]

    Article • Schizophrenia Research, October 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  512. Reduced platelet vesicular monoamine transporter density in smoking schizophrenia patients

    Article • European Neuropsychopharmacology, October 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  513. Anti-proliferative activity of haloperidol in B16 mouse and human SK-MEL-28 melanoma cell lines

    Article • International Journal of Oncology, October 2005, Spandidos Publications

    Prof ABRAHAM WEIZMAN

  514. Impact of Gastric Banding on Plasma Ghrelin, Growth Hormone, Cortisol, DHEA and DHEA-S Levels

    Article • Obesity Surgery, September 2005, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  515. Platelet vesicular monoamine transporter density in untreated patients diagnosed with social phobia

    Article • Psychiatry Research, September 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  516. A95 DHEA ATTENUATES COCAINE-SEEKING BEHAVIOR IN THE SELF-ADMINISTRATION MODEL IN RATS

    Article • Behavioural Pharmacology, September 2005, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  517. B10 EFFECT OF SELECTED ANTIDEPRESSANTS ON INFLAMMATORY PROCESSES ASSOCIATED WITH MODEL OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE) IN MICE

    Article • Behavioural Pharmacology, September 2005, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  518. A83 NOVEL ANTIPSYCHOTIC WITH DOPAMINE ANTAGONISM AND GABAERGIC ACTIVITY

    Article • Behavioural Pharmacology, September 2005, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  519. The effect of 17β estradiol withdrawal on the level of brain and peripheral neurosteroids in ovarectomized rats

    Article • Neuroscience Letters, August 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  520. Expressed Emotion: Relevance to Rehospitalization in Schizophrenia Over 7 Years

    Article • Schizophrenia Bulletin, July 2005, Oxford University Press (OUP)

    Prof ABRAHAM WEIZMAN

  521. Family-based association study of 5-HT2A receptor T102C polymorphism and suicidal behavior in Ashkenazi inpatient adolescents

    Article • International Journal of Adolescent Medicine and Health, July 2005, De Gruyter

    Prof ABRAHAM WEIZMAN

  522. The Peripheral-Type Benzodiazepine Receptor and Tumorigenicity:  Isoquinoline Binding Protein (IBP) Antisense Knockdown in the C6 Glioma Cell Line†

    Article • Biochemistry, July 2005, American Chemical Society (ACS)

    Prof ABRAHAM WEIZMAN

  523. Corneal temperature in schizophrenia patients

    Article • The International Journal of Neuropsychopharmacology, June 2005, Oxford University Press (OUP)

    Prof ABRAHAM WEIZMAN

  524. Dopamine transporter haplotype and attention-deficit hyperactivity disorder

    Article • Molecular Psychiatry, May 2005, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  525. Cortisol/Dehydroepiandrosterone Ratio and Responses to Antipsychotic Treatment in Schizophrenia

    Article • Neuropsychopharmacology, May 2005, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  526. Errata

    Article • Comprehensive Psychiatry, May 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  527. Lowered DHEA-S plasma levels in adult individuals with autistic disorder

    Article • European Neuropsychopharmacology, May 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  528. Six-Week Open-Label Reboxetine Treatment in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, May 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  529. The involvement of dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS) in blocking the therapeutic effect of electroconvulsive shocks in an animal model of depression

    Article • European Neuropsychopharmacology, May 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  530. The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia

    Article • European Neuropsychopharmacology, May 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  531. Obsessive and Compulsive Symptoms in Schizophrenia Patients--From Neuropsychology to Clinical Typology and Classification

    Article • Journal of Neuropsychiatry, May 2005, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  532. Ondansetron Treatment in Tourette's Disorder

    Article • The Journal of Clinical Psychiatry, April 2005, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  533. Reboxetine as an Optional Treatment for Hyperkinetic Conduct Disorder: A Prospective Open-Label Trial

    Article • Journal of Child and Adolescent Psychopharmacology, April 2005, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  534. Cancer in schizophrenia: is the risk higher or lower?

    Article • Schizophrenia Research, March 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  535. Decreased platelet vesicular monoamine transporter density in children and adolescents with attention deficit/hyperactivity disorder

    Article • European Neuropsychopharmacology, March 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  536. Decreased platelet vesicular monoamine transporter density in habitual smokers

    Article • European Neuropsychopharmacology, March 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  537. Is brain dehydroepiandrosterone synthesis modulated by free radicals in mice?

    Article • Neuroscience Letters, March 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  538. Repeated swim stress leads to down-regulation of vesicular monoamine transporter 2 in rat brain nucleus accumbens and striatum

    Article • European Neuropsychopharmacology, March 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  539. The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients

    Article • International Clinical Psychopharmacology, March 2005, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  540. Impaired procedural learning in obsessive?compulsive disorder and Parkinson's disease, but not in major depressive disorder

    Article • Behavioural Brain Research, February 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  541. Relationships between serotonin transporter promoter polymorphism, platelet serotonin transporter binding and clinical phenotype in suicidal and non-suicidal adolescent inpatients

    Article • Acta Neurovegetativa, February 2005, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  542. Reply to Problems in Assessing Musical Hallucination

    Article • The Journal of Clinical Psychiatry, January 2005, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  543. Effects of climate on admission rates of schizophrenia patients to psychiatric hospitals

    Article • European Psychiatry, January 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  544. A Possible Antienuretic Effect of Reboxetine in Children and Adolescents with Attention Deficit/Hyperactivity Disorder: Case Series

    Article • Neuropsychobiology, January 2005, Karger Publishers

    Prof ABRAHAM WEIZMAN

  545. Familial aggregation of schizophrenia-spectrum disorders and obsessive-compulsive associated disorders in schizophrenia probands with and without OCD

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, January 2005, Wiley

    Prof ABRAHAM WEIZMAN

  546. New drug targets for depression and anxiety: Is the peptides era arriving?

    Article • Drug Development Research, January 2005, Wiley

    Prof ABRAHAM WEIZMAN

  547. The 5-HT1D receptor agonist zolmitriptan for neuroleptic-induced akathisia: an open label preliminary study

    Article • International Clinical Psychopharmacology, January 2005, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  548. P.3.07 Antipsychotic agents and neuromusculardysfunction

    Article • European Neuropsychopharmacology, January 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  549. Differential Induction of Apoptosis by Antidepressants in Glioma and Neuroblastoma Cell Lines: Evidence for p-c-Jun, Cytochrome c, and Caspase-3 Involvement

    Article • Journal of Molecular Neuroscience, January 2005, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  550. P.2.014 The effect of DHEA administrationon extrapyramidal symptoms in schizophrenia: A randomized double blind placebo controlled trial

    Article • European Neuropsychopharmacology, January 2005, Elsevier

    Prof ABRAHAM WEIZMAN

  551. A Case of Hyponatremia Associated With Escitalopram

    Article • The Journal of Clinical Psychiatry, December 2004, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  552. Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology

    Article • Schizophrenia Research, December 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  553. Psychosocial situations, quality of depression and schizophrenia in adolescents

    Article • Psychiatry Research, December 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  554. CAG repeat polymorphism within theKCNN3 gene is a significant contributor to susceptibility to anorexia nervosa: A case-control study of female patients and several ethnic groups in the Israeli Jewish population

    Article • American Journal of Medical Genetics, November 2004, Wiley

    Prof ABRAHAM WEIZMAN

  555. P.1.057 Characterization of the serotonin transporterand its modulation by antidepressants in peripheral blood lymphocytes

    Article • European Neuropsychopharmacology, October 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  556. P5.014 Decreased platelet vesicular monoaminetransporter density in habitual smokers

    Article • European Neuropsychopharmacology, October 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  557. P.2.052 Electroencephalographic changes in chronic neuroleptic-resistant schizophrenia patients during clozapine treatment

    Article • European Neuropsychopharmacology, October 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  558. P.2.082 Neuromuscular dysfunction in neuroleptics-treatedpsychiatric patients

    Article • European Neuropsychopharmacology, October 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  559. S.07.05 Rivastigmine therapy for memory deficits in schizophrenia patients receiving electroconvulsive treatment

    Article • European Neuropsychopharmacology, October 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  560. P.1.075 SSRI's therapy in depressive outpatients:Personality changes and predictors of response

    Article • European Neuropsychopharmacology, October 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  561. Influence of 17β-estradiol on the synthesis of reduced neurosteroids in the brain (in vivo) and in glioma cells (in vitro): possible relevance to mental disorders in women

    Article • Brain Research, September 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  562. Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients

    Article • European Neuropsychopharmacology, August 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  563. Dimensional complexity of the neuronal activity in a rat model of depression

    Article • Neuroreport, August 2004, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  564. Involvement of the neuropeptide corticotropin-releasing hormone in an animal model of Shigella-related seizures

    Article • Journal of Neuroimmunology, August 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  565. Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines

    Article • Biochemical Pharmacology, August 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  566. The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot study

    Article • European Neuropsychopharmacology, August 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  567. The utility of the Visual Analogue Scale for the assessment of depressive mood in cognitively impaired patients

    Article • International Journal of Geriatric Psychiatry, July 2004, Wiley

    Prof ABRAHAM WEIZMAN, Dr. Ron Milo

  568. Beneficial Effects of Gonadotropin-Releasing Hormone Analogue Treatment on Positive and Negative Symptoms of Schizophrenia

    Article • The Journal of Clinical Psychiatry, July 2004, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  569. Complexity of the dynamic QT variability and RR variability in patients with acute anterior wall myocardial infarction

    Article • Journal of Electrocardiology, July 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  570. Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study

    Article • Human Psychopharmacology Clinical and Experimental, July 2004, Wiley

    Prof ABRAHAM WEIZMAN

  571. Serum prolactin levels in unmedicated first-episode and recurrent schizophrenia patients: a possible marker for the disease's subtypes

    Article • Psychiatry Research, July 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  572. DRD4 receptor gene exon III polymorphism in inpatient suicidal adolescents

    Article • Acta Neurovegetativa, June 2004, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  573. Mianserin for the rapid improvement of chronic akathisia in a schizophrenia patient

    Article • European Psychiatry, June 2004, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  574. Biochemical and pharmacological characterization of the serotonin transporter in human peripheral blood lymphocytes

    Article • European Neuropsychopharmacology, May 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  575. COMT: A common susceptibility gene in bipolar disorder and schizophrenia

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, April 2004, Wiley

    Prof ABRAHAM WEIZMAN

  576. D2 Antagonist Augmentation in Patients with a Partial Response to Atypical Antipsychotics

    Article • The Canadian Journal of Psychiatry, April 2004, SAGE Publications

    Prof ABRAHAM WEIZMAN

  577. Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus

    Article • Biological Psychiatry, April 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  578. Electroconvulsive therapy in adolescent and adult psychiatric inpatients—a retrospective chart design

    Article • Journal of Affective Disorders, March 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  579. Alterations in QT dispersion in medicated schizophrenia patients following electroconvulsive therapy

    Article • European Neuropsychopharmacology, March 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  580. Chronic lithium treatment affects rat brain and serum dehydroepiandrosterone (DHEA) and DHEA-sulphate (DHEA-S) levels

    Article • The International Journal of Neuropsychopharmacology, March 2004, Oxford University Press (OUP)

    Prof ABRAHAM WEIZMAN

  581. Clozapine in the Treatment of Obsessive-compulsive Symptoms in Schizophrenia Patients: A Case Series Study

    Article • Pharmacopsychiatry, March 2004, Thieme Publishing Group

    Prof ABRAHAM WEIZMAN

  582. Cysteine-induced hypoglycemic brain damage: an alternative mechanism to excitotoxicity

    Article • Amino Acids, March 2004, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  583. Heart Rate Variability in Patients With Major Depression

    Article • Psychosomatics, March 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  584. Personalized psychiatry: a realistic goal

    Article • Pharmacogenomics, March 2004, Future Medicine

    Prof ABRAHAM WEIZMAN

  585. The relation between latent inhibition and symptom-types in young schizophrenics

    Article • Behavioural Brain Research, March 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  586. Musical Hallucinations: Prevalence in Psychotic and Nonpsychotic Outpatients

    Article • The Journal of Clinical Psychiatry, February 2004, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  587. Admission rates of bipolar depressed patients increase during spring/summer and correlate with maximal environmental temperature

    Article • Bipolar Disorders, February 2004, Wiley

    Prof ABRAHAM WEIZMAN

  588. An Open-Label Trial of Sildenafil Addition in Risperidone-Treated Male Schizophrenia Patients With Erectile Dysfunction

    Article • The Journal of Clinical Psychiatry, January 2004, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  589. Obsessive-Compulsive Disorder in Schizophrenia

    Article • CNS Drugs, January 2004, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  590. Benefit-Risk Assessment of Atypical Antipsychotics in the Treatment of Schizophrenia and Comorbid Disorders in Children and Adolescents

    Article • Drug Safety, January 2004, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  591. Characterization of Phenothiazine-Induced Apoptosis in Neuroblastoma and Glioma Cell Lines: Clinical Relevance and Possible Application for Brain-Derived Tumors

    Article • Journal of Molecular Neuroscience, January 2004, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  592. Heart rate variability increases in elderly depressed patients who respond to electroconvulsive therapy

    Article • Journal of Psychosomatic Research, January 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  593. Lack of Plasma Norepinephrine Cyclicity, Increased Estradiol during the Follicular Phase, and of Progesterone and Gonadotrophins at Ovulation in Women with Premenstrual Syndrome

    Article • Neuropsychobiology, January 2004, Karger Publishers

    Prof ABRAHAM WEIZMAN

  594. Low Platelet-Poor Plasma Levels of Serotonin in Adult Autistic Patients

    Article • Neuropsychobiology, January 2004, Karger Publishers

    Prof ABRAHAM WEIZMAN

  595. QT dispersion in patients with social phobia

    Article • Journal of Affective Disorders, January 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  596. Sexual Dimorphism in obsessive-compulsive disorder

    Article • The World Journal of Biological Psychiatry, January 2004, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  597. Sulpiride augmentation of olanzapine in the management of treatment-resistant chronic schizophrenia: evidence for improvement of mood symptomatology

    Article • International Clinical Psychopharmacology, January 2004, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  598. The Influence of Parturition on the Level and Synthesis of Sulfated and Free Neurosteroids in Rats

    Article • Neuropsychobiology, January 2004, Karger Publishers

    Prof ABRAHAM WEIZMAN

  599. Genetic, developmental, and physical factors associated with attention deficit hyperactivity disorder in patients with velocardiofacial syndrome

    Article • American Journal of Medical Genetics, January 2004, Wiley

    Prof ABRAHAM WEIZMAN

  600. Obsessive-compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome

    Article • American Journal of Medical Genetics, January 2004, Wiley

    Prof ABRAHAM WEIZMAN

  601. P.3.18 Rivastigmine therapy for memory deficits in schizophrenia patients receiving electroconvulsive treatment

    Article • European Neuropsychopharmacology, January 2004, Elsevier

    Prof ABRAHAM WEIZMAN

  602. Defense Mechanisms in a Community-Based Sample of Female Adolescents with Partial Eating Disorders

    Article • The International Journal of Psychiatry in Medicine, December 2003, SAGE Publications

    Prof ABRAHAM WEIZMAN

  603. Granulocytopenia associated with neuroleptic therapy in a patient with benign familial leukopenia

    Article • International Journal of Psychiatry in Clinical Practice, December 2003, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  604. NQO2 gene is associated with clozapine-induced agranulocytosis

    Article • Tissue Antigens, December 2003, Wiley

    Prof ABRAHAM WEIZMAN

  605. Comparison of Clinical Characteristics and Comorbidity in Schizophrenia Patients With and Without Obsessive-Compulsive Disorder

    Article • The Journal of Clinical Psychiatry, November 2003, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  606. Decreased platelet peripheral-type benzodiazepine receptors in persistently violent schizophrenia patients

    Article • Journal of Psychiatric Research, November 2003, Elsevier

    Prof ABRAHAM WEIZMAN

  607. Methylphenidate Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents With Velocardiofacial Syndrome

    Article • The Journal of Clinical Psychiatry, October 2003, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  608. Brain neurosteroid changes after paroxetine administration in mice

    Article • European Neuropsychopharmacology, October 2003, Elsevier

    Prof ABRAHAM WEIZMAN

  609. Variability of Color Choice in the Lüscher Color Test—Sex Differences

    Article • Perceptual and Motor Skills, October 2003, SAGE Publications

    Prof ABRAHAM WEIZMAN

  610. P.2.001 The effects of antipsychotic agents on sceletal muscle of psychiatric patients as it evidences by their serum creatine kinase activity

    Article • European Neuropsychopharmacology, October 2003, Elsevier

    Prof ABRAHAM WEIZMAN

  611. Comparison of ego defenses among physically abused children, neglected, and non-maltreated children

    Article • Comprehensive Psychiatry, September 2003, Elsevier

    Prof ABRAHAM WEIZMAN

  612. Effectiveness, Safety, and Tolerability of Risperidone in Adolescents with Schizophrenia: An Open-Label Study

    Article • Journal of Child and Adolescent Psychopharmacology, September 2003, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  613. Olanzapine Treatment in Chronic Drug-Resistant Childhood-Onset Schizophrenia: An Open-Label Study

    Article • Journal of Child and Adolescent Psychopharmacology, September 2003, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  614. Risperidone, but Not Olanzapine, Decreases Bone Mineral Density in Female Premenopausal Schizophrenia Patients

    Article • The Journal of Clinical Psychiatry, July 2003, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  615. The Effects of Clozapine Versus Haloperidol on Measures of Impulsive Aggression and Suicidality in Chronic Schizophrenia Patients

    Article • The Journal of Clinical Psychiatry, July 2003, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  616. Depression and suicidal behavior in adolescent inpatients with obsessive compulsive disorder

    Article • Journal of Affective Disorders, July 2003, Elsevier

    Prof ABRAHAM WEIZMAN

  617. Selegiline in the Treatment of Sexual Dysfunction in Schizophrenic Patients Maintained on Neuroleptics: A Pilot Study

    Article • Clinical Neuropharmacology, July 2003, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  618. Efficacy of Low-Dose Mirtazapine in Neuroleptic-Induced Akathisia: A Double-Blind Randomized Placebo-Controlled Pilot Study

    Article • Journal of Clinical Psychopharmacology, June 2003, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  619. Article • Journal of Clinical Psychopharmacology, June 2003, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  620. Olanzapine-Sertraline Combination in Schizophrenia With Obsessive-Compulsive Disorder

    Article • The Journal of Clinical Psychiatry, May 2003, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  621. DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic study

    Article • European Neuropsychopharmacology, May 2003, Elsevier

    Prof ABRAHAM WEIZMAN

  622. Oral health and treatment needs of institutionalized chronic psychiatric patients in Israel

    Article • European Psychiatry, May 2003, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  623. Precautionary measures reduce risk of definite neuroleptic malignant syndrome in newly typical neuroleptic-treated schizophrenia inpatients

    Article • International Clinical Psychopharmacology, May 2003, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  624. Treatment of Neuroleptic-Induced Akathisia With the 5-HT2A Antagonist Trazodone

    Article • Clinical Neuropharmacology, May 2003, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  625. Bidirectional Concentration-Dependent Effects of Tumor Necrosis Factor Alpha in Shigella dysenteriae-Related Seizures

    Article • Infection and Immunity, April 2003, ASM Journals

    Prof ABRAHAM WEIZMAN

  626. Alternation learning in OCD/schizophrenia patients

    Article • European Neuropsychopharmacology, March 2003, Elsevier

    Prof ABRAHAM WEIZMAN

  627. Amantadine as augmentation therapy in the management of treatment-resistant depression

    Article • International Clinical Psychopharmacology, March 2003, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  628. Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depression

    Article • Brain Research, March 2003, Elsevier

    Prof ABRAHAM WEIZMAN

  629. Education: Teaching pharmacogenomics to prepare future physicians and researchers for personalized medicine

    Article • Trends in Pharmacological Sciences, March 2003, Elsevier

    Prof ABRAHAM WEIZMAN

  630. Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled study

    Article • European Neuropsychopharmacology, March 2003, Elsevier

    Prof ABRAHAM WEIZMAN

  631. The incidence of the serum creatine kinase elevation in schizophrenia and schizoaffective patients during antipsychotic treatment

    Article • Schizophrenia Research, March 2003, Elsevier

    Prof ABRAHAM WEIZMAN

  632. Attenuation of Olanzapine-Induced Weight Gain With Reboxetine in Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study

    Article • American Journal of Psychiatry, February 2003, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  633. Dehydroepiandrosterone Augmentation in the Management of Negative, Depressive, and Anxiety Symptoms in Schizophrenia

    Article • Archives of General Psychiatry, February 2003, American Medical Association (AMA)

    Prof ABRAHAM WEIZMAN

  634. Beneficial Effect of Donepezil Augmentation for the Management of Comorbid Schizophrenia and Dementia

    Article • Clinical Neuropharmacology, January 2003, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  635. Clozapine decreases rat brain dehydroepiandrosterone and dehydroepiandrosterone sulfate levels

    Article • European Neuropsychopharmacology, January 2003, Elsevier

    Prof ABRAHAM WEIZMAN

  636. Increased corneal temperature in drug-free male schizophrenia patients

    Article • European Neuropsychopharmacology, January 2003, Elsevier

    Prof ABRAHAM WEIZMAN

  637. Lower Corneal Temperature in Neuroleptic-Treated vs. Drug-Free Schizophrenia Patients

    Article • Neuropsychobiology, January 2003, Karger Publishers

    Prof ABRAHAM WEIZMAN

  638. Neuroimaging communality between schizophrenia and obsessive compulsive disorder: A putative basis for schizo-obsessive disorder?

    Article • The World Journal of Biological Psychiatry, January 2003, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  639. Plasma Testosterone Levels in Patients with Combat-Related Posttraumatic Stress Disorder

    Article • Neuropsychobiology, January 2003, Karger Publishers

    Prof ABRAHAM WEIZMAN

  640. Platelet-Associated Antibodies Mediate Protective Autoimmune Response in Schizophrenia

    Article • Neuropsychobiology, January 2003, Karger Publishers

    Prof ABRAHAM WEIZMAN

  641. Sildenafil for Selective Serotonin Reuptake Inhibitor-Induced Erectile Dysfunction in Elderly Male Depressed Patients

    Article • Journal of Sex & Marital Therapy, January 2003, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  642. Substantial increase in number and dosage of antipsychotics in non-responsive vs. responsive schizophrenia inpatients

    Article • International Journal of Psychiatry in Clinical Practice, January 2003, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  643. The Drug-User Husband and His Wife: Attachment Styles, Family Cohesion, and Adaptability

    Article • Substance Use & Misuse, January 2003, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  644. The platelet-poor plasma 5-HT response to carbohydrate rich meal administration in adult autistic patients compared with normal controls

    Article • Human Psychopharmacology Clinical and Experimental, January 2003, Wiley

    Prof ABRAHAM WEIZMAN

  645. Three-Month Treatment Course of Methylphenidate Increases Plasma Levels of Dehydroepiandrosterone (DHEA) and Dehydroepiandrosterone-Sulfate (DHEA-S) in Attention Deficit Hyperactivity Disorder

    Article • Neuropsychobiology, January 2003, Karger Publishers

    Prof ABRAHAM WEIZMAN

  646. A Highly Significant Association between a COMT Haplotype and Schizophrenia

    Article • The American Journal of Human Genetics, December 2002, Elsevier

    Prof ABRAHAM WEIZMAN

  647. Elevated platelet vesicular monoamine transporter density in untreated patients diagnosed with major depression

    Article • Psychiatry Research, November 2002, Elsevier

    Prof ABRAHAM WEIZMAN

  648. Individual and familial psychopathology among hospitalized minors at risk, juvenile delinquents, and psychiatric controls

    Article • International Journal of Law and Psychiatry, November 2002, Elsevier

    Prof ABRAHAM WEIZMAN

  649. Sexual Function and Behavior in Social Phobia

    Article • The Journal of Clinical Psychiatry, October 2002, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  650. Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: A double-blind randomized placebo-controlled pilot study

    Article • European Neuropsychopharmacology, October 2002, Elsevier

    Prof ABRAHAM WEIZMAN

  651. Association between flupenthixol treatment and emergence of manic symptoms

    Article • European Psychiatry, October 2002, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  652. Antipsychotic agents and serum creatine kinase levels

    Article • European Neuropsychopharmacology, October 2002, Elsevier

    Prof ABRAHAM WEIZMAN

  653. Increased platelet vesicular monoamine transporter density in untreated major depressed patients

    Article • European Neuropsychopharmacology, October 2002, Elsevier

    Prof ABRAHAM WEIZMAN

  654. Reboxetine but not fluoxetine attenuates olanzapine-induced weight gain in first-episode schizophrenia patients

    Article • European Neuropsychopharmacology, October 2002, Elsevier

    Prof ABRAHAM WEIZMAN

  655. Use of dehydroepiandrosterone in the management of negative symptoms of schizophrenia

    Article • European Neuropsychopharmacology, October 2002, Elsevier

    Prof ABRAHAM WEIZMAN

  656. Anticholinergic Burden and the Risk of Falls Among Elderly Psychiatric Inpatients: A 4-Year Case-Control Study

    Article • International Psychogeriatrics, September 2002, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  657. Ziprasidone Alternative for Olanzapine-Induced Hyperglycemia

    Article • American Journal of Psychiatry, September 2002, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  658. Serum Creatine Kinase Levels in Untreated Hospitalized Adolescents During Acute Psychosis

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, September 2002, Elsevier

    Prof ABRAHAM WEIZMAN

  659. Increased platelet vesicular monoamine transporter density in adult schizophrenia patients

    Article • European Neuropsychopharmacology, August 2002, Elsevier

    Prof ABRAHAM WEIZMAN

  660. Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2

    Article • European Neuropsychopharmacology, June 2002, Elsevier

    Prof ABRAHAM WEIZMAN

  661. High Serum Creatinine Kinase Level: Possible Risk Factor for Neuroleptic Malignant Syndrome

    Article • Journal of Clinical Psychopharmacology, June 2002, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  662. Olanzapine-Induced Weight Gain in Patients With First-Episode Schizophrenia: A Double-Blind, Placebo-Controlled Study of Fluoxetine Addition

    Article • American Journal of Psychiatry, June 2002, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  663. Weight Gain Associated With Increased Food Intake and Low Habitual Activity Levels in Male Adolescent Schizophrenic Inpatients Treated With Olanzapine

    Article • American Journal of Psychiatry, June 2002, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  664. Head circumference and incident Alzheimer's disease: Modification by apolipoprotein E

    Article • Neurology, May 2002, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  665. An association of CAG repeats at the KCNN3 locus with symptom dimensions of schizophrenia

    Article • Biological Psychiatry, May 2002, Elsevier

    Prof ABRAHAM WEIZMAN

  666. Psychiatric comorbidity in schizophrenia with obsessive compulsive disorder

    Article • European Psychiatry, May 2002, Elsevier

    Prof ABRAHAM WEIZMAN

  667. Creatine kinase levels during treatment with atypical antipsychotic agents

    Article • European Psychiatry, May 2002, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  668. Seasonality of birth in patients with type 1 diabetes

    Article • The Lancet, April 2002, Elsevier

    Prof ABRAHAM WEIZMAN

  669. The NR2B subunit of glutamate receptors as a potential target for relieving chronic pain: prospects and concerns

    Article • Drug Discovery Today, April 2002, Elsevier

    Prof ABRAHAM WEIZMAN

  670. Seasonality of birth in patients with type 1 diabetes

    Article • The Lancet, April 2002, Elsevier

    Prof ABRAHAM WEIZMAN

  671. Mianserin or placebo as adjuncts to typical antipsychotics in resistant schizophrenia

    Article • International Clinical Psychopharmacology, March 2002, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  672. PK 11195 attenuates kainic acid-induced seizures and alterations in peripheral-type benzodiazepine receptor (PBR) protein components in the rat brain

    Article • Journal of Neurochemistry, March 2002, Wiley

    Prof ABRAHAM WEIZMAN

  673. SOCIODEMOGRAPHIC FACTORS ASSOCIATED WITH ATTEMPTED SUICIDE IN TWO ISRAELI CITIES BETWEEN 1990 AND 1998

    Article • The Journal of Nervous and Mental Disease, February 2002, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  674. Enhancement of pentylenetetrazole-induced seizures by Shigella dysenteriae in LPS-resistant C3H/HeJ mice: role of the host response

    Article • Medical Microbiology and Immunology, January 2002, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  675. Association between anorexia nervosa and the hsKCa3 gene: a family-based and case control study

    Article • Molecular Psychiatry, January 2002, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  676. Article • Sexuality and Disability, January 2002, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  677. Familial Expressed Emotion: Outcome and Course of Israeli Patients With Schizophrenia

    Article • Schizophrenia Bulletin, January 2002, Oxford University Press (OUP)

    Prof ABRAHAM WEIZMAN

  678. Preferential transmission of interleukin-1 receptor antagonist alleles in attention deficit hyperactivity disorder

    Article • Molecular Psychiatry, January 2002, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  679. Article • Journal of Child and Family Studies, January 2002, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  680. Safety and efficacy of long-term low-dose clozapine aftercare treatment in a patient with learning difficulties who suffered from neuroleptic malignant syndrome

    Article • International Journal of Psychiatry in Clinical Practice, January 2002, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  681. Short-term treatment of post-traumatic stress disorder with naltrexone: an open-label preliminary study

    Article • Human Psychopharmacology Clinical and Experimental, January 2002, Wiley

    Prof ABRAHAM WEIZMAN

  682. Sildenafil Citrate for the Sexual Dysfunction in Antidepressant-Treated Male Patients with Posttraumatic Stress Disorder

    Article • Psychotherapy and Psychosomatics, January 2002, Karger Publishers

    Prof ABRAHAM WEIZMAN

  683. Association between anorexia nervosa and the hsKCa3 gene: a family-based and case control study

    Article • Molecular Psychiatry, January 2002, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  684. Preferential transmission of interleukin-1 receptor antagonist alleles in attention deficit hyperactivity disorder

    Article • Molecular Psychiatry, January 2002, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  685. Association between severity of schizophrenic symptoms and urinary retention

    Article • European Psychiatry, December 2001, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  686. Attachment Styles and Aggression in Physically Abused and Neglected Children

    Article • Journal of Youth and Adolescence, December 2001, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  687. Cyproheptadine Versus Propranolol for the Treatment of Acute Neuroleptic-Induced Akathisia: A Comparative Double-Blind Study

    Article • Journal of Clinical Psychopharmacology, December 2001, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  688. Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson’s disease

    Article • Neuroscience Letters, December 2001, Elsevier

    Prof ABRAHAM WEIZMAN

  689. Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells

    Article • British Journal of Cancer, November 2001, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  690. Acute and Repeated Swim Stress Effects on Peripheral Benzodiazepine Receptors in the Rat Hippocampus, Adrenal, and Kidney,

    Article • Neuropsychopharmacology, November 2001, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  691. Fatty acid amide hydrolase inhibitors and the marijuana debate

    Article • The Lancet, November 2001, Elsevier

    Prof ABRAHAM WEIZMAN

  692. Stability of diagnosis: a 20-year retrospective cohort study of Israeli psychiatric adolescent inpatients

    Article • Journal of Adolescence, October 2001, Elsevier

    Prof ABRAHAM WEIZMAN

  693. Analysis of neurosteroid levels in attention deficit hyperactivity disorder

    Article • The International Journal of Neuropsychopharmacology, September 2001, Oxford University Press (OUP)

    Prof ABRAHAM WEIZMAN

  694. Characterization of high-affinity [3H]TBZOH binding to the human platelet vesicular monoamine transporter

    Article • Life Sciences, September 2001, Elsevier

    Prof ABRAHAM WEIZMAN

  695. Zuclopenthixol Treatment of Behavioral Disturbances in Mentally Retarded Children and Adolescents: An Open-Label Study

    Article • Journal of Child and Adolescent Psychopharmacology, September 2001, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  696. Abnormal thermoregulation in drug-free male schizophrenia patients

    Article • European Neuropsychopharmacology, August 2001, Elsevier

    Prof ABRAHAM WEIZMAN

  697. Animal models and human genome diversity: the pitfalls of inbred mice

    Article • Drug Discovery Today, August 2001, Elsevier

    Prof ABRAHAM WEIZMAN

  698. Effectiveness of dynamic cognitive intervention in rehabilitation of clients with schizophrenia

    Article • Clinical Rehabilitation, August 2001, SAGE Publications

    Prof ABRAHAM WEIZMAN

  699. Heart Rate Variability in Elderly Patients Before and After Electroconvulsive Therapy

    Article • American Journal of Geriatric Psychiatry, August 2001, Elsevier

    Prof ABRAHAM WEIZMAN

  700. Hormonal Regulation of Peripheral Benzodiazepine Receptor Binding Properties Is Mediated by Subunit Interaction

    Article • Biochemistry, July 2001, American Chemical Society (ACS)

    Prof ABRAHAM WEIZMAN

  701. Comparison of Sexual Dysfunction in Male Schizophrenic Patients Maintained on Treatment With Classical Antipsychotics Versus Clozapine

    Article • The Journal of Clinical Psychiatry, July 2001, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  702. Response of Catatonia to Risperidone: Two Case Reports

    Article • Clinical Neuropharmacology, July 2001, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  703. Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: A new approach to an old problem

    Article • The British Journal of Psychiatry, July 2001, Royal College of Psychiatrists

    Prof ABRAHAM WEIZMAN

  704. Use and cost of outpatient visits of AD patients: CERAD XXII

    Article • Neurology, June 2001, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  705. Heart Rate Variability in Elderly Patients Before and After Electroconvulsive Therapy

    Article • American Journal of Geriatric Psychiatry, June 2001, Elsevier

    Prof ABRAHAM WEIZMAN

  706. Obsessive–compulsive disorder in hospitalized patients with chronic schizophrenia

    Article • Psychiatry Research, May 2001, Elsevier

    Prof ABRAHAM WEIZMAN

  707. Geriatric Depression Scale (GDS-15): A Sensitive and Convenient Instrument for Measuring Depression in Young Anorexic Patients

    Article • The Journal of Nervous and Mental Disease, May 2001, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  708. Mirtazapine for Neuroleptic-Induced Akathisia

    Article • American Journal of Psychiatry, May 2001, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  709. Metabolic bioenergy homeostatic disruption: a cause of anorexia nervosa

    Article • Medical Hypotheses, April 2001, Elsevier

    Prof ABRAHAM WEIZMAN

  710. Modeling the Volcanism on Mars

    Article • Icarus, April 2001, Elsevier

    Prof ABRAHAM WEIZMAN

  711. Risperidone-Induced Retrograde Ejaculation

    Article • American Journal of Psychiatry, April 2001, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  712. Association of anorexia nervosa with the high activity allele of the COMT gene: a family-based study in Israeli patients

    Article • Molecular Psychiatry, March 2001, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  713. Subjective effects of MDMA (‘Ecstasy’) on human sexual function

    Article • European Psychiatry, March 2001, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  714. Familial Approach To The Treatment Of Childhood Obesity: Conceptual Model

    Article • Journal of Nutrition Education, March 2001, Elsevier

    Prof ABRAHAM WEIZMAN

  715. Obsessive-Compulsive Schizophrenia: A New Diagnostic Entity?

    Article • Journal of Neuropsychiatry, February 2001, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  716. Obsessive-Compulsive Schizophrenia: A New Diagnostic Entity?

    Article • Journal of Neuropsychiatry, February 2001, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  717. Aggravation of food-related behavior in an adolescent with Prader-Willi syndrome treated with fluvoxamine and fluoxetine

    Article • International Journal of Eating Disorders, January 2001, Wiley

    Prof ABRAHAM WEIZMAN

  718. Article • Journal of Autism and Developmental Disorders, January 2001, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  719. Case control and family-based studies of tryptophan hydroxylase gene A218C polymorphism and suicidality in adolescents

    Article • American Journal of Medical Genetics, January 2001, Wiley

    Prof ABRAHAM WEIZMAN

  720. Changes in Vesicular Monoamine Transporter (VMAT2) and Synaptophysin in Rat Substantia nigra and Prefrontal Cortex Induced by Psychotropic Drugs

    Article • Neuropsychobiology, January 2001, Karger Publishers

    Prof ABRAHAM WEIZMAN

  721. Depressive symptoms and suicidality in physically abused children.

    Article • American Journal of Orthopsychiatry, January 2001, American Psychological Association (APA)

    Prof ABRAHAM WEIZMAN

  722. Article • Cellular and Molecular Neurobiology, January 2001, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  723. Family-based association study of serotonin transporter promoter in suicidal adolescents: No association with suicidality but possible role in violence traits

    Article • American Journal of Medical Genetics, January 2001, Wiley

    Prof ABRAHAM WEIZMAN

  724. Insulin, Insulin-like Growth Factors-I and -II and Insulin-like Growth Factor Binding Protein-3 in Newborn Serum: Association with Normal Fetal Head Growth and Head Circumference

    Article • Journal of Pediatric Endocrinology and Metabolism, January 2001, De Gruyter

    Prof ABRAHAM WEIZMAN

  725. Plasma serotonin response to carbohydrate-rich food in chronic schizophrenic patients: clozapine versus classic antipsychotic agents

    Article • Human Psychopharmacology Clinical and Experimental, January 2001, Wiley

    Prof ABRAHAM WEIZMAN

  726. The influence of three months of methylphenidate treatment on platelet-poor plasma biogenic amine levels in boys with attention deficit hyperactivity disorder

    Article • Human Psychopharmacology Clinical and Experimental, January 2001, Wiley

    Prof ABRAHAM WEIZMAN

  727. Viewpoint: Obsessive Compulsive Behaviour in Autism - Towards an Autistic-Obsessive Compulsive Syndrome?

    Article • The World Journal of Biological Psychiatry, January 2001, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  728. The Antiaggressive Action of Combined Haloperidol-Propranolol Treatment in Schizophrenia

    Article • European Psychologist, December 2000, Hogrefe Publishing Group

    Prof ABRAHAM WEIZMAN

  729. Acute antipsychotic drug administration lowers body temperature in drug-free male schizophrenic patients

    Article • European Neuropsychopharmacology, December 2000, Elsevier

    Prof ABRAHAM WEIZMAN

  730. Hemispheric function in disorganized type schizophrenia: performance on the Quality Extinction Test

    Article • European Psychiatry, November 2000, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  731. QT dispersion in the surface electrocardiogram in elderly patients with major depression

    Article • Journal of Affective Disorders, November 2000, Elsevier

    Prof ABRAHAM WEIZMAN

  732. Basal plasma dehydroepiandrosterone sulfate level: a possible predictor for response to electroconvulsive therapy in depressed psychotic inpatients

    Article • Biological Psychiatry, October 2000, Elsevier

    Prof ABRAHAM WEIZMAN

  733. Beneficial effect of the addition of the 5-HT 2A/2C and α2 antagonist mianserin to ongoing haloperidol treatment in drug-resistant chronically hospitalized schizophrenic patients

    Article • European Psychiatry, September 2000, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  734. Elevated circulatory level of GABAA – antagonistic neurosteroids in patients with combat-related post-traumatic stress disorder

    Article • Psychological Medicine, September 2000, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  735. Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia

    Article • European Neuropsychopharmacology, September 2000, Elsevier

    Prof ABRAHAM WEIZMAN

  736. Myotoxicity and Neurotoxicity during Clozapine Treatment

    Article • Clinical Neuropharmacology, September 2000, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  737. Prospective evaluation of circulatory levels of catecholamines and serotonin in neuroleptic malignant syndrome

    Article • Acta Psychiatrica Scandinavica, September 2000, Wiley

    Prof ABRAHAM WEIZMAN

  738. Treating Depression in Alzheimer's Disease: Integration of Differing Guidelines

    Article • International Psychogeriatrics, September 2000, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  739. Dopamine D4 receptor gene polymorphism and personality traits in healthy volunteers

    Article • European Archives of Psychiatry and Clinical Neuroscience, August 2000, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  740. Is Melatonin Treatment Effective for Tardive Dyskinesia?

    Article • The Journal of Clinical Psychiatry, August 2000, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  741. Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse

    Article • Pharmacogenomics, August 2000, Future Medicine

    Prof ABRAHAM WEIZMAN

  742. Frequency of neuroleptic malignant syndrome in a large psychiatric hospital in Moscow

    Article • European Psychiatry, August 2000, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  743. Heat Intolerance in Patients With Chronic Schizophrenia Maintained With Antipsychotic Drugs

    Article • American Journal of Psychiatry, August 2000, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  744. Homeostatic biophasal conscious regulation

    Article • Medical Hypotheses, August 2000, Elsevier

    Prof ABRAHAM WEIZMAN

  745. Human Figure Drawings in the Evaluation of Severe Adolescent Suicidal Behavior

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, August 2000, Elsevier

    Prof ABRAHAM WEIZMAN

  746. The wired network as a learning paradigm for normal and abnormal brain neuronal communication

    Article • Medical Hypotheses, August 2000, Elsevier

    Prof ABRAHAM WEIZMAN

  747. Abnormal neuronal ionic flux activity: learning paradigms of schizophrenic thought disorders

    Article • Medical Hypotheses, July 2000, Elsevier

    Prof ABRAHAM WEIZMAN

  748. Effect of diazepam on the immune response of rats exposed to acute and chronic swim stress

    Article • Biomedicine & Pharmacotherapy, July 2000, Elsevier

    Prof ABRAHAM WEIZMAN

  749. Unaltered α2-noradrenergic/imidazoline receptors in suicide victims: a postmortem brain autoradiographic analysis

    Article • European Neuropsychopharmacology, July 2000, Elsevier

    Prof ABRAHAM WEIZMAN

  750. Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia

    Article • European Neuropsychopharmacology, May 2000, Elsevier

    Prof ABRAHAM WEIZMAN

  751. Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms

    Article • International Clinical Psychopharmacology, May 2000, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  752. Suppression of serum gonadal steroids in rats by chronic treatment with dopamine and serotonin reuptake inhibitors

    Article • European Neuropsychopharmacology, May 2000, Elsevier

    Prof ABRAHAM WEIZMAN

  753. Haloperidol - induced neurotoxicity - possible implications for tardive dyskinesia

    Article • Acta Neurovegetativa, April 2000, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  754. Increased Risk for Dementia in Elderly Psychiatric Inpatients with Late-Onset Major Depression

    Article • The Journal of Nervous and Mental Disease, April 2000, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  755. Search for association between suicide attempt and serotonergic polymorphisms

    Article • Psychiatric Genetics, March 2000, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  756. Article • Child Psychiatry & Human Development, January 2000, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  757. Combined Electroconvulsive-Clozapine Therapy

    Article • Clinical Neuropharmacology, January 2000, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  758. LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study

    Article • International Clinical Psychopharmacology, January 2000, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  759. Lifetime psychiatric comorbidity rate in Israeli non-help-seeking patients with combat-related post-traumatic stress disorder

    Article • Journal of Affective Disorders, January 2000, Elsevier

    Prof ABRAHAM WEIZMAN

  760. Neuroeyndocrinological Response to Standardized Mixed Meal in Female Anorectic Patients During Active and Refeeding Phases

    Article • Journal of Pediatric Endocrinology and Metabolism, January 2000, De Gruyter

    Prof ABRAHAM WEIZMAN

  761. Obsessive-compulsive disorder in first episode and chronic schizophrenic patients

    Article • Schizophrenia Research, January 2000, Elsevier

    Prof ABRAHAM WEIZMAN

  762. Impact of Treatment for Childhood Obesity on Parental Risk Factors for Cardiovascular Disease

    Article • Preventive Medicine, December 1999, Elsevier

    Prof ABRAHAM WEIZMAN

  763. Insulin-like-growth-factor-I (IGF-I) antagonizes apoptosis induced by serum deficiency and doxorubicin in neuronal cell culture

    Article • Growth Hormone & IGF Research, December 1999, Elsevier

    Prof ABRAHAM WEIZMAN

  764. Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma☆☆☆★

    Article • Journal of Allergy and Clinical Immunology, December 1999, Elsevier

    Prof ABRAHAM WEIZMAN

  765. The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: An open label study

    Article • European Neuropsychopharmacology, December 1999, Elsevier

    Prof ABRAHAM WEIZMAN

  766. Role of Nitric Oxide in the Enhancement of Pentylenetetrazole-Induced Seizures Caused by Shigella dysenteriae

    Article • Infection and Immunity, December 1999, ASM Journals

    Prof ABRAHAM WEIZMAN

  767. Obsessive-Compulsive Disorder in Patients With First-Episode Schizophrenia

    Article • American Journal of Psychiatry, December 1999, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  768. Partial eating disorders in newly drafted female recruits in Israel

    Article • Archives of Women s Mental Health, November 1999, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  769. Elevated Cellular Immune Response to Human Heat-Shock Protein-60 in Schizophrenic Patients

    Article • European Archives of Psychiatry and Clinical Neuroscience, November 1999, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  770. Lack of efficacy of the 5-HT3 receptor antagonist granisetron in the treatment of acute neuroleptic-induced akathisia

    Article • International Clinical Psychopharmacology, November 1999, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  771. Ondansetron treatment in patients with Tourette??s syndrome

    Article • International Clinical Psychopharmacology, November 1999, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  772. Effects of psychotropic drugs on cell proliferation and differentiation

    Article • Biochemical Pharmacology, October 1999, Elsevier

    Prof ABRAHAM WEIZMAN

  773. Is there sexual dimorphism in obsessive-compulsive disorder?

    Article • Neuroscience & Biobehavioral Reviews, October 1999, Elsevier

    Prof ABRAHAM WEIZMAN

  774. Platelet Peripheral-Type Benzodiazepine in Pregnancy and Lactation

    Article • Neuropsychopharmacology, October 1999, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  775. Orbitofrontal cortex dysfunction in obsessive–compulsive disorder?

    Article • European Neuropsychopharmacology, September 1999, Elsevier

    Prof ABRAHAM WEIZMAN

  776. Orbitofrontal cortex dysfunction in obsessive-compulsive disorder?

    Article • European Neuropsychopharmacology, September 1999, Elsevier

    Prof ABRAHAM WEIZMAN

  777. Decreased platelet peripheral-type benzodiazepine receptors in adolescent inpatients with repeated suicide attempts

    Article • Biological Psychiatry, August 1999, Elsevier

    Prof ABRAHAM WEIZMAN

  778. Serum cholesterol, suicidal tendencies, impulsivity, aggression, and depression in adolescent psychiatric inpatients

    Article • Biological Psychiatry, August 1999, Elsevier

    Prof ABRAHAM WEIZMAN

  779. Clozapine in elderly psychiatric patients: Tolerability, safety, and efficacy

    Article • Comprehensive Psychiatry, July 1999, Elsevier

    Prof ABRAHAM WEIZMAN

  780. The effect of long-term antipsychotic treatment on the body weight of patients suffering from chronic schizophrenia: clozapine versus classical antipsychotic agents

    Article • International Clinical Psychopharmacology, July 1999, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  781. Lack of association between suicide attempt and a polymorphism at the dopamine receptor D4 locus

    Article • Psychiatric Genetics, June 1999, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  782. Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity diiorder

    Article • Acta Psychiatrica Scandinavica, April 1999, Wiley

    Prof ABRAHAM WEIZMAN

  783. Homicide by schizophrenic patients in Israel

    Article • European Psychiatry, April 1999, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  784. Low platelet-poor plasma concentrations of serotonin in patients with combat-related posttraumatic stress disorder

    Article • Biological Psychiatry, April 1999, Elsevier

    Prof ABRAHAM WEIZMAN

  785. 3H-Spiperone Binding to Lymphocytes in Neuroleptic-Naive-Schizophrenia and the Effect of Neuroleptic Treatment

    Article • Clinical Neuropharmacology, March 1999, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  786. Biophysical shunt theory for neuropsychopathology: biphasal homeostatic dysregulation

    Article • Medical Hypotheses, March 1999, Elsevier

    Prof ABRAHAM WEIZMAN

  787. Biophysical shunt theory for neuropsychopathology: neuroimmunological causality for the suicide condition

    Article • Medical Hypotheses, March 1999, Elsevier

    Prof ABRAHAM WEIZMAN

  788. Biophysical shunt theory for neuropsychopathology: pentaphasic lipid-induced model for schizophrenia

    Article • Medical Hypotheses, March 1999, Elsevier

    Prof ABRAHAM WEIZMAN

  789. Fluvoxamine treatment of obsessivecompulsive symptoms in schizophrenic patients: an add-on open study

    Article • International Clinical Psychopharmacology, March 1999, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  790. The Impact of Clozapine Treatment on Serum Lipids in Chronic Schizophrenic Patients

    Article • Clinical Neuropharmacology, March 1999, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  791. Involvement of Tumor Necrosis Factor Alpha and Interleukin-1β in Enhancement of Pentylenetetrazole-Induced Seizures Caused byShigella dysenteriae

    Article • Infection and Immunity, March 1999, ASM Journals

    Prof ABRAHAM WEIZMAN

  792. Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin

    Article • The British Journal of Psychiatry, March 1999, Royal College of Psychiatrists

    Prof ABRAHAM WEIZMAN

  793. Article • Child Psychiatry & Human Development, January 1999, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  794. Clinical characteristics of schizophrenia associated with velo-cardio-facial syndrome

    Article • Schizophrenia Research, January 1999, Elsevier

    Prof ABRAHAM WEIZMAN

  795. Intramuscular Flunitrazepam Versus Intramuscular Haloperidol in the Emergency Treatment of Aggressive Psychotic Behavior

    Article • American Journal of Psychiatry, January 1999, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  796. Use of Atypical Neuroleptics in Child and Adolescent Psychiatry

    Article • The Journal of Clinical Psychiatry, December 1998, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  797. Role of behaviour modification in the treatment of childhood obesity with the parents as the exclusive agents of change

    Article • International Journal of Obesity, December 1998, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  798. Elevated surum creatine kinase activity in adolescent psychiatric inpatients on admission

    Article • International Clinical Psychopharmacology, November 1998, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  799. Sleep Disturbances in Children with Attention-Deficit/Hyperactivity Disorder

    Article • Journal of Learning Disabilities, November 1998, SAGE Publications

    Prof ABRAHAM WEIZMAN

  800. Antiproliferative and differentiating effects of benzodiazepine receptor ligands on B16 melanoma cells

    Article • Biochemical Pharmacology, October 1998, Elsevier

    Prof ABRAHAM WEIZMAN

  801. Reliability and validity of the Family Eating and Activity Habits Questionnaire

    Article • European Journal of Clinical Nutrition, September 1998, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  802. Bone age in adolescents with schizophrenia and obsessive-compulsive disorder

    Article • Schizophrenia Research, September 1998, Elsevier

    Prof ABRAHAM WEIZMAN

  803. Interventional catheterization decreases plasma levels of atrial natriuretic peptide (ANP) in children with congenital heart defects

    Article • Catheterization and Cardiovascular Diagnosis, September 1998, Wiley

    Prof ABRAHAM WEIZMAN

  804. The antinociceptive effect of moclobemide in mice is mediated by noradrenergic pathways

    Article • Neuroscience Letters, September 1998, Elsevier

    Prof ABRAHAM WEIZMAN

  805. The suicide brain: a review of postmortem receptor/transporter binding studies

    Article • Neuroscience & Biobehavioral Reviews, September 1998, Elsevier

    Prof ABRAHAM WEIZMAN

  806. Zuclopenthixol, D1/D2 antagonist, for treatment of chronic aggressive schizophrenia and psychotic oligophrenic patients

    Article • European Psychiatry, August 1998, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  807. Linkage disequilibrium of common Gaucher disease mutations with a polymorphic site in thepyruvate kinase (PKLR) gene

    Article • American Journal of Medical Genetics, July 1998, Wiley

    Prof ABRAHAM WEIZMAN

  808. Elevated adhesiveness/aggregation of peripheral blood leukocytes in patients with major depression

    Article • Journal of Affective Disorders, July 1998, Elsevier

    Prof ABRAHAM WEIZMAN

  809. Intravenous Clomipramine for a Schizophrenic Patient With Obsessive-Compulsive Symptoms

    Article • American Journal of Psychiatry, July 1998, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  810. Low-Dose Mianserin in Treatment of Acute Neuroleptic-Induced Akathisia

    Article • Journal of Clinical Psychopharmacology, June 1998, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  811. Parents as the exclusive agents of change in the treatment of childhood obesity

    Article • American Journal of Clinical Nutrition, June 1998, Oxford University Press (OUP)

    Prof ABRAHAM WEIZMAN

  812. Regulation of rat brain vesicular monoamine transporter by chronic treatment with ovarian hormones

    Article • Molecular Brain Research, June 1998, Elsevier

    Prof ABRAHAM WEIZMAN

  813. Clinico-tremorgraphic features of neuroleptic-induced tremor

    Article • International Clinical Psychopharmacology, May 1998, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  814. Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis

    Article • International Clinical Psychopharmacology, May 1998, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  815. Psychiatric and polysomnographic evaluation of sleep disturbances

    Article • Journal of Affective Disorders, April 1998, Elsevier

    Prof ABRAHAM WEIZMAN

  816. Geriatric Depression Scale-Short Form–Validity and Reliability of the Hebrew Version

    Article • Clinical Gerontologist, March 1998, The Haworth Press

    Prof ABRAHAM WEIZMAN

  817. HLA-B38 and clozapine-induced agranulocytosis in Israeli Jewish schizophrenic patients

    Article • European Journal of Immunogenetics, February 1998, Wiley

    Prof ABRAHAM WEIZMAN

  818. Recurrence pattern of serum creatine phosphokinase levels in repeated acute psychosis

    Article • Biological Psychiatry, February 1998, Elsevier

    Prof ABRAHAM WEIZMAN

  819. Backpropagation and adaptive resonance theory in predicting suicidal risk

    Article • Medical Informatics, January 1998, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  820. Belief in Transmigration of the Soul and Psychopathology in Israeli Druze

    Article • Psychopathology, January 1998, Karger Publishers

    Prof ABRAHAM WEIZMAN

  821. Combined clozapine-lithium treatment for schizophrenia and schizoaffective disorder

    Article • European Psychiatry, January 1998, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  822. Lateral preference in post-traumatic stress disorder

    Article • Psychological Medicine, January 1998, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  823. Article • Annals of Clinical Psychiatry, January 1998, Portico

    Prof ABRAHAM WEIZMAN

  824. Selective Serotonin Reuptake Inhibitor and Akathisia

    Article • Journal of Clinical Psychopharmacology, December 1997, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  825. Sulpiride augmentation in people with schizophrenia partially responsive to clozapine

    Article • The British Journal of Psychiatry, December 1997, Royal College of Psychiatrists

    Prof ABRAHAM WEIZMAN

  826. Velocardiofacial manifestations and microdeletions in schizophrenic inpatients

    Article • American Journal of Medical Genetics, November 1997, Wiley

    Prof ABRAHAM WEIZMAN

  827. Successful treatment of fluoxetine-indueed dystonia with low-dose mianserin

    Article • Movement Disorders, November 1997, Wiley

    Prof ABRAHAM WEIZMAN

  828. Effect of neuroleptics on neuronal cell viability in primary mouse embryo brain cultures and a neuroblastoma cell-line, relevance to tardive dyskinesia

    Article • Neuroscience Letters, November 1997, Elsevier

    Prof ABRAHAM WEIZMAN

  829. Plasma neurosteroids (DHEA and DHEA-S) as markers of successful responsiveness to ECT (electroconvulsive therapy) in psychiatric patients

    Article • Neuroscience Letters, November 1997, Elsevier

    Prof ABRAHAM WEIZMAN

  830. Regulation of rat brain vesicular monoamine transporter (VMAT2) by chronic treatment with ovarian hormones

    Article • Neuroscience Letters, November 1997, Elsevier

    Prof ABRAHAM WEIZMAN

  831. The antinociceptive effect of moclobemide is mediated by noradrenergic pathways

    Article • Neuroscience Letters, November 1997, Elsevier

    Prof ABRAHAM WEIZMAN

  832. The interaction between the female hormonal system and the gene for the peripheral-type benzodiazepine receptor

    Article • Neuroscience Letters, November 1997, Elsevier

    Prof ABRAHAM WEIZMAN

  833. Reduction of Aggressiveness and Impulsiveness during Clozapine Treatment in Chronic Neuroleptic-Resistant Schizophrenic Patients

    Article • Clinical Neuropharmacology, October 1997, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  834. Elevated levels of serum interleukin-1β in combat-related posttraumatic stress disorder

    Article • Biological Psychiatry, September 1997, Elsevier

    Prof ABRAHAM WEIZMAN

  835. Desmopressin (DDAVP) treatment in adult sleep-related enuresis

    Article • Human Psychopharmacology Clinical and Experimental, September 1997, Wiley

    Prof ABRAHAM WEIZMAN

  836. Serotonergic agents in the treatment of acute neuroleptic-induced akathisia

    Article • International Clinical Psychopharmacology, September 1997, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  837. Partial Eating Disorders in a Community Sample of Female Adolescents

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, August 1997, Elsevier

    Prof ABRAHAM WEIZMAN

  838. Clozapine Treatment for Neuroleptic-Induced Tardive Dyskinesia, Parkinsonism, and Chronic Akathisia in Schizophrenic Patients

    Article • The Journal of Clinical Psychiatry, July 1997, Physicians Postgraduate Press, Inc

    Prof ABRAHAM WEIZMAN

  839. THE ROLE OF INTELLIGENCE AND HYPERACTIVITY IN DIAGNOSIS OF ATTENTION DEFICIT DISORDER IN CHILDREN AND ADOLESCENTS

    Article • International Journal of Adolescent Medicine and Health, July 1997, De Gruyter

    Prof ABRAHAM WEIZMAN

  840. Trihexyphenidyl treatment of clozapine-induced hypersalivation

    Article • International Clinical Psychopharmacology, July 1997, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  841. Neuroleptic malignant syndrome with gangliosidosis type II

    Article • Biological Psychiatry, June 1997, Elsevier

    Prof ABRAHAM WEIZMAN

  842. Evidence for an infectious etiology in autism

    Article • Pathophysiology, June 1997, Elsevier

    Prof ABRAHAM WEIZMAN

  843. Mianserin, a 5-HT2a/2c and α2 Antagonist, in the Treatment of Sexual Dysfunction Induced by Serotonin Reuptake Inhibitors

    Article • Clinical Neuropharmacology, June 1997, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  844. Significant Inhibition of Spontaneous IgA Secretion by Selective Peripheral-Type Benzodiazepine Receptor Ligands

    Article • Clinical Neuropharmacology, June 1997, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  845. An open trial of clozapine in neuroleptic-resistant childhood-onset schizophrenia

    Article • The British Journal of Psychiatry, June 1997, Royal College of Psychiatrists

    Prof ABRAHAM WEIZMAN

  846. Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters

    Article • Brain Research, May 1997, Elsevier

    Prof ABRAHAM WEIZMAN

  847. Phase transitions and melting in Mars

    Article • Journal of Geophysical Research Atmospheres, April 1997, American Geophysical Union (AGU)

    Prof ABRAHAM WEIZMAN

  848. Role of lipid-induced changes in plasma membrane in the biophysical shunt theory of psychopathology

    Article • Medical Hypotheses, April 1997, Elsevier

    Prof ABRAHAM WEIZMAN

  849. Cerebral bioimpedance pattern as a function of psychiatric signs and symptoms

    Article • Medical Hypotheses, February 1997, Elsevier

    Prof ABRAHAM WEIZMAN

  850. Iron Treatment in Children with Attention Deficit Hyperactivity Disorder

    Article • Neuropsychobiology, January 1997, Karger Publishers

    Prof ABRAHAM WEIZMAN

  851. Sulpiride adjunction to clozapine in treatment-resistant schizophrenic patients: a preliminary case series study

    Article • European Psychiatry, January 1997, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  852. Lithium and Male Sexual Function in Affective Patients

    Article • Clinical Neuropharmacology, December 1996, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  853. Severe withdrawal akathisia following neuroleptic discontinuation successfully controlled by clozapine

    Article • International Clinical Psychopharmacology, December 1996, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  854. Hypothalamic-pituitary-ovarian axis and mood

    Article • Biological Psychiatry, November 1996, Elsevier

    Prof ABRAHAM WEIZMAN

  855. Serotonergic Drugs in Trichotillomania: Treatment Results in 12 Patients

    Article • The Journal of Nervous and Mental Disease, October 1996, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  856. Low-Dose imipramine for thioridazineinduced male orgasmic disorder

    Article • Journal of Sex & Marital Therapy, September 1996, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  857. Neuroleptic malignant syndrome associated with abrupt withdrawal of anticholinergic agents

    Article • International Clinical Psychopharmacology, September 1996, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  858. Trihexyphenidyl (Artane) abuse in schizophrenic patients

    Article • International Clinical Psychopharmacology, September 1996, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  859. Differential effect of insulin-like growth factor-I and growth hormone on hypothalamic regulation of growth hormone secretion in the rat

    Article • Journal of Endocrinological Investigation, September 1996, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  860. Fluvoxamine Treatment in Clozapine-Induced Obsessive-Compulsive Symptoms in Schizophrenic Patients

    Article • Clinical Neuropharmacology, August 1996, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  861. Obsessive-Compulsive Characteristics: From Symptoms to Syndrome

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, July 1996, Elsevier

    Prof ABRAHAM WEIZMAN

  862. Biophysical shunt theory for neuropsychopathology part II: Neuronal network miswiring

    Article • Medical Hypotheses, June 1996, Elsevier

    Prof ABRAHAM WEIZMAN

  863. Chronic GnRH agonist administration down-regulates platelet serotonin transporter in women undergoing assisted reproductive treatment

    Article • Psychopharmacology, May 1996, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  864. HLA-B38 and clozapine agranulocytosis in Israeli Jewish schizophrenia patients

    Article • Human Immunology, April 1996, Elsevier

    Prof ABRAHAM WEIZMAN

  865. TNFa microsatellite AC/GT repeat polymorphism and clozapine agranulocytosis in Israeli Jewish schizophrenia patients

    Article • Human Immunology, April 1996, Elsevier

    Prof ABRAHAM WEIZMAN

  866. Depression in women treated with a gonadotropinreleasing hormone agonist

    Article • Biological Psychiatry, March 1996, Elsevier

    Prof ABRAHAM WEIZMAN

  867. Trihexyphenidyl as a possible therapeutic option in clozapine-induced nocturnal enuresis

    Article • International Clinical Psychopharmacology, March 1996, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  868. Combined clozapine-lithium treatment in schizophrenia and schizoaffective disorder

    Article • Schizophrenia Research, February 1996, Elsevier

    Prof ABRAHAM WEIZMAN

  869. Antinuclear autoantibodies in relation to bipolar affective disorder and lithium therapy

    Article • European Psychiatry, January 1996, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  870. Auditory Pseudohallucinations Induced by a Combination of Hearing Impairment and Environmental Stress

    Article • Psychopathology, January 1996, Karger Publishers

    Prof ABRAHAM WEIZMAN

  871. Constraints on the structure and composition of Mars from thermal evolution models

    Article • Journal of Geophysical Research Atmospheres, January 1996, American Geophysical Union (AGU)

    Prof ABRAHAM WEIZMAN

  872. Functional hemisphere imbalance in patients with paranoid or disorganized schizophrenia

    Article • European Psychiatry, January 1996, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  873. Safety and effectiveness of combined ECT and clozapine in treatment-resistant mania

    Article • European Psychiatry, January 1996, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  874. Comparative models of Uranus and Neptune

    Article • Planetary and Space Science, December 1995, Elsevier

    Prof ABRAHAM WEIZMAN

  875. Suicide as a Work Accident

    Article • Journal of Forensic Psychiatry, December 1995, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  876. Akathisia-like behavior following ECT, and its successful treatment with low-close mianserin

    Article • International Clinical Psychopharmacology, November 1995, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  877. Biophysical shunt theory for neuropsychopathology: Part I

    Article • Medical Hypotheses, November 1995, Elsevier

    Prof ABRAHAM WEIZMAN

  878. Lithium-induced akathisia responds to low-dose mianserin

    Article • International Clinical Psychopharmacology, November 1995, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  879. Fluvoxamine treatment of compulsivity, impulsivity, and aggression

    Article • American Journal of Psychiatry, November 1995, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  880. Antinuclear autoantibodies in chronic schizophrenia

    Article • Acta Psychiatrica Scandinavica, October 1995, Wiley

    Prof ABRAHAM WEIZMAN

  881. Cyproheptadine Treatment in Neuroleptic-Induced Akathisia

    Article • The British Journal of Psychiatry, October 1995, Royal College of Psychiatrists

    Prof ABRAHAM WEIZMAN

  882. Cytokine production in drug-free and neuroleptic-treated schizophrenic patients

    Article • Biological Psychiatry, September 1995, Elsevier

    Prof ABRAHAM WEIZMAN

  883. Cyproheptadine Treatment of Sexual Dysfunction Induced by Serotonin Reuptake Inhibitors

    Article • Clinical Neuropharmacology, August 1995, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  884. Effect of melatonin on active transport of serotonin into blood platelets

    Article • Psychiatry Research, July 1995, Elsevier

    Prof ABRAHAM WEIZMAN

  885. Beneficial effect of low-dose mianserin on fluvoxamine-induced akathisia in an obsessive-compulsive patient

    Article • International Clinical Psychopharmacology, June 1995, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  886. An Animal Model for the Study of Neurotoxicity of Bacterial Products and Application of the Model to Demonstrate that Shiga Toxin and Lipopolysaccharide Cooperate in Inducing Neurologic Disorders

    Article • The Journal of Infectious Diseases, May 1995, Oxford University Press (OUP)

    Prof ABRAHAM WEIZMAN

  887. Constitutive heterochromatin of chromosome 1 and Duffy blood group alleles in schizophrenia

    Article • American Journal of Medical Genetics, April 1995, Wiley

    Prof ABRAHAM WEIZMAN

  888. Platelet peripheral-type benzodiazepine receptor in major depression

    Article • Journal of Affective Disorders, April 1995, Elsevier

    Prof ABRAHAM WEIZMAN

  889. Reduction in serotonin 5HT2 receptor binding on platelets of delinquent adolescents

    Article • Psychopharmacology, April 1995, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  890. Caffeine withdrawal increases lithium blood levels

    Article • Biological Psychiatry, March 1995, Elsevier

    Prof ABRAHAM WEIZMAN

  891. Catatonia as an Unusual Presentation of Posttraumatic Stress Disorder

    Article • Psychopathology, January 1995, Karger Publishers

    Prof ABRAHAM WEIZMAN

  892. Lack of association between cholesterol blood levels and platelet serotonin uptake

    Article • European Psychiatry, January 1995, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  893. The Belief in the Transmigration of Souls as a Presenting Symptom of Generalized Anxiety Disorder in a Military Setting

    Article • Psychopathology, January 1995, Karger Publishers

    Prof ABRAHAM WEIZMAN

  894. Verapamil treatment in clozapine-induced sleep-related enuresis: a case report

    Article • European Psychiatry, January 1995, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  895. The psychobiology of obsessive-compulsive disorder

    Article • European Neuropsychopharmacology, September 1994, Elsevier

    Prof ABRAHAM WEIZMAN

  896. Cortisol and prolactin response to fenfluramine in suicidal patients

    Article • European Neuropsychopharmacology, September 1994, Elsevier

    Prof ABRAHAM WEIZMAN

  897. Verapamil Is Not an Antidepressant in Patients Resistant to Tricyclic Antidepressants

    Article • Clinical Neuropharmacology, June 1994, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  898. Anticipatory consent for psychiatric treatment: A potential solution for an ethical problem

    Article • Journal of Forensic Psychiatry, May 1994, Taylor & Francis

    Prof ABRAHAM WEIZMAN

  899. Interactions between laudanosine, GABA, and opioid subtype receptors: implication for laudanosine seizure activity

    Article • Brain Research, May 1994, Elsevier

    Prof ABRAHAM WEIZMAN

  900. Cortisol and prolactin response to fenfluramine in suicidal patients

    Article • Biological Psychiatry, May 1994, Elsevier

    Prof ABRAHAM WEIZMAN

  901. Gonadotropin-releasing-hormone agonist induces depression in women

    Article • Biological Psychiatry, May 1994, Elsevier

    Prof ABRAHAM WEIZMAN

  902. Platelet serotonin transporter in drug-naive migrainous children and adolescents

    Article • Biological Psychiatry, April 1994, Elsevier

    Prof ABRAHAM WEIZMAN

  903. Tourette's disorder: Is there an association with the antiphospholipid syndrome?

    Article • Biological Psychiatry, April 1994, Elsevier

    Prof ABRAHAM WEIZMAN

  904. Fluvoxamine Open-Label Treatment of Adolescent Inpatients with Obsessive-Compulsive Disorder or Depression

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, March 1994, Elsevier

    Prof ABRAHAM WEIZMAN

  905. Brief Report

    Article • Clinical Neuropharmacology, February 1994, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  906. Psychiatric Aspects of Hyperemesis gravidarum

    Article • Psychotherapy and Psychosomatics, January 1994, Karger Publishers

    Prof ABRAHAM WEIZMAN

  907. Clozapine Treatment in Very Early Onset Schizophrenia

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, January 1994, Elsevier

    Prof ABRAHAM WEIZMAN

  908. Internality and externality correlates of potential drivers among high school pupils in Holon (Israel)

    Article • International Journal of Risk & Safety in Medicine, January 1994, IOS Press

    Prof ABRAHAM WEIZMAN

  909. The Sociocultural Theory in the Development of Anorexia nervosa

    Article • Psychopathology, January 1994, Karger Publishers

    Prof ABRAHAM WEIZMAN

  910. Erratum

    Article • Developmental Brain Research, October 1993, Elsevier

    Prof ABRAHAM WEIZMAN

  911. An Epidemiologic Study of Gilles de la Tourette's Syndrome in Israel

    Article • Archives of General Psychiatry, September 1993, American Medical Association (AMA)

    Prof ABRAHAM WEIZMAN

  912. Post-psychotic depression in schizophrenia

    Article • European Archives of Psychiatry and Clinical Neuroscience, September 1993, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  913. POST MORTEM COMPUTERIZED TOMOGRAPHY IN TRAUMA VICTIMS. A NEW METHOD OF PM DIAGNOSIS

    Article • Journal of Trauma and Acute Care Surgery, July 1993, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  914. Hippocampal γ-aminobutyric acid and benzodiazepine receptors after early phenobarbital exposure

    Article • Developmental Brain Research, July 1993, Elsevier

    Prof ABRAHAM WEIZMAN

  915. Repeated swim-stress reduces GABAA receptor α subunit mRNAs in the mouse hippocampus

    Article • Molecular Brain Research, May 1993, Elsevier

    Prof ABRAHAM WEIZMAN

  916. Reduced total complement haemolytic activity in schizophrenic patients

    Article • Psychological Medicine, May 1993, Cambridge University Press

    Prof ABRAHAM WEIZMAN

  917. Adrenal mitochondrial benzodiazepine receptors are sensitive to agents active at the dopamine receptor

    Article • Biochemical Pharmacology, March 1993, Elsevier

    Prof ABRAHAM WEIZMAN

  918. Long-Term Testosterone or Diethylstilbestrol Treatment Affects Gamma-Aminobutyric Acid and Central-Type Benzodiazepine Receptors but Not Peripheral-Type Benzodiazepine Receptors in the Female Rat Brain

    Article • Neuroendocrinology, January 1993, Karger Publishers

    Prof ABRAHAM WEIZMAN

  919. Ro 5-4864 and PK 11195, but Not Diazepam, Depress Cardiac Function in an Isolated Working Rat Heart Model

    Article • Pharmacology, January 1993, Karger Publishers

    Prof ABRAHAM WEIZMAN

  920. Seizures induced by combined levomepromazine-fluvoxamine treatment

    Article • International Clinical Psychopharmacology, January 1993, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  921. Survey of Smoking Habits and Attitudes of Patients and Staff in Psychiatric Hospitals

    Article • Psychopathology, January 1993, Karger Publishers

    Prof ABRAHAM WEIZMAN

  922. Clozapine—lithium combined treatment and agranulocytosis

    Article • International Clinical Psychopharmacology, January 1993, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  923. An Epidemiological Study of Obsessive-Compulsive Disorder and Related Disorders in Israeli Adolescents

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, November 1992, Elsevier

    Prof ABRAHAM WEIZMAN

  924. Elevated Plasma Immunoreactive β-Endorphin in Anorexia Nervosa

    Article • Clinical Neuropharmacology, October 1992, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  925. Risk for Definite Neuroleptic Malignant Syndrome

    Article • The British Journal of Psychiatry, August 1992, Royal College of Psychiatrists

    Prof ABRAHAM WEIZMAN

  926. More Fluoxetine Experience

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, July 1992, Elsevier

    Prof ABRAHAM WEIZMAN

  927. ??-Tocopherol Treatment for Tardive Dyskinesia

    Article • The Journal of Nervous and Mental Disease, June 1992, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  928. Decreased platelet imipramine binding in tourette syndrome children with obsessive-compulsive disorder

    Article • Biological Psychiatry, April 1992, Elsevier

    Prof ABRAHAM WEIZMAN

  929. Acute Transient Stress-Induced Hallucinations in Soldiers

    Article • The British Journal of Psychiatry, March 1992, Royal College of Psychiatrists

    Prof ABRAHAM WEIZMAN

  930. Neuroendocrine Response to Trihexyphenidyl in Depressed Patients

    Article • Clinical Neuropharmacology, February 1992, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  931. Testosterone prevents castration-induced reduction in peripheral benzodiazepine receptors in Cowper's gland and adrenal

    Article • Brain Research, February 1992, Elsevier

    Prof ABRAHAM WEIZMAN

  932. Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice

    Article • International Journal of Oncology, January 1992, Spandidos Publications

    Prof ABRAHAM WEIZMAN

  933. Behavioral Profile and Social Competence in Temporal Lobe Epilepsy of Adolescence

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, November 1991, Elsevier

    Prof ABRAHAM WEIZMAN

  934. Haloperidol and lithium carbonate treatment did not influence serum immunoglobulin levels in schizophrenic and affective patients

    Article • Acta Psychiatrica Scandinavica, September 1991, Wiley

    Prof ABRAHAM WEIZMAN

  935. TRH stimulation test in obsessive-compulsive patients

    Article • Psychiatry Research, July 1991, Elsevier

    Prof ABRAHAM WEIZMAN

  936. Peripheral benzodiazepine receptors on platelets in chronic and detoxified alcoholics☆

    Article • Neuropharmacology, June 1991, Elsevier

    Prof ABRAHAM WEIZMAN

  937. Platelet peripheral benzodiazepine receptors in repeated stress

    Article • Life Sciences, January 1991, Elsevier

    Prof ABRAHAM WEIZMAN

  938. Parental Anxiety Associated with a Child's Bronchial Asthma

    Article • Pediatric Asthma Allergy &amp Immunology, January 1991, Mary Ann Liebert Inc

    Prof ABRAHAM WEIZMAN

  939. True Conversive Hallucinations

    Article • Psychopathology, January 1991, Karger Publishers

    Prof ABRAHAM WEIZMAN

  940. Food deprivation modulates γ-aminobutyric acid receptors and peripheral benzodiazepine binding sites in rats

    Article • Brain Research, December 1990, Elsevier

    Prof ABRAHAM WEIZMAN

  941. Platelet benzodiazepine binding in Alzheimer's disease

    Article • Biological Psychiatry, October 1990, Elsevier

    Prof ABRAHAM WEIZMAN

  942. Identification and distribution of peripheral benzodiazepine binding sites in male rat genital tract

    Article • Biochemical Pharmacology, August 1990, Elsevier

    Prof ABRAHAM WEIZMAN

  943. Adrenalectomy prevents the stress-induced decrease in in vitro [3H]Ro15-1788 binding to GABAA benzodiazepine receptors in the mouse

    Article • Brain Research, June 1990, Elsevier

    Prof ABRAHAM WEIZMAN

  944. Long-term verapamil treatment increases [3H]imipramine binding in human platelets

    Article • European Journal of Pharmacology, June 1990, Elsevier

    Prof ABRAHAM WEIZMAN

  945. Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment

    Article • Acta Psychiatrica Scandinavica, February 1990, Wiley

    Prof ABRAHAM WEIZMAN

  946. Application of Basic Neuroscience to Child Psychiatry

    Article • January 1990, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  947. Introduction

    Article • January 1990, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  948. Biological Studies of Attention-Deficit Disorder

    Article • January 1990, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  949. Role of the GABA—Benzodiazepine Receptor Complex in Stress

    Article • January 1990, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  950. Effect of prenatal and neonatal chronic exposure to phenobarbital on central and peripheral benzodiazepine receptors

    Article • Brain Research, January 1990, Elsevier

    Prof ABRAHAM WEIZMAN

  951. Prolonged Fear of AIDS as an Early Symptom of Schizophrenia

    Article • Psychopathology, January 1990, Karger Publishers

    Prof ABRAHAM WEIZMAN

  952. Chronic phenobarbital administration affects GABA and benzodiazepine receptors in the brain and periphery

    Article • European Journal of Pharmacology, October 1989, Elsevier

    Prof ABRAHAM WEIZMAN

  953. Stress-induced behavioral depression in the rat is associated with a decrease in GABA receptor-mediated chloride ion flux and brain benzodiazepine receptor occupancy

    Article • Brain Research, May 1989, Elsevier

    Prof ABRAHAM WEIZMAN

  954. LIGANDS SPECIFIC TO PERIPHERAL BENZODIAZEPINE RECEPTORS FOR TREATMENT OF PORPHYRIAS

    Article • The Lancet, April 1989, Elsevier

    Prof ABRAHAM WEIZMAN

  955. High Affinity Imipramine Binding and Serotonin Uptake in Human Platelets as a Peripheral Biological Marker in Neuropsychiatric Disorders

    Article • January 1989, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  956. Examination stress, platelet peripheral benzodiazepine binding sites, and plasma hormone levels

    Article • Life Sciences, January 1989, Elsevier

    Prof ABRAHAM WEIZMAN

  957. Primary Hyperparathyroidism, Psychiatric Manifestations, Diagnosis and Management

    Article • Psychotherapy and Psychosomatics, January 1989, Karger Publishers

    Prof ABRAHAM WEIZMAN

  958. Suicide by Related Kidney Donors following the Recipients’ Death

    Article • Psychotherapy and Psychosomatics, January 1989, Karger Publishers

    Prof ABRAHAM WEIZMAN

  959. Tricyclic antidepressants and calcium channel blockers: interactions at the (−)-desmethoxyverapamil binding site and the serotonin transporter

    Article • European Journal of Pharmacology, October 1988, Elsevier

    Prof ABRAHAM WEIZMAN

  960. Vitamin B12and folic acid serum levels in obsessive compulsive disorder

    Article • Acta Psychiatrica Scandinavica, July 1988, Wiley

    Prof ABRAHAM WEIZMAN

  961. Plasma Cortisol, Prolactin, Growth Hormone, and Immunoreactive β-Endorphin Response to Fenfluramine Challenge in Depressed Patients

    Article • Clinical Neuropharmacology, June 1988, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  962. The Sigma Receptor

    Article • Clinical Neuropharmacology, April 1988, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  963. Imipramine binding to platelets of children with attention deficit disorder with hyperactivity

    Article • Biological Psychiatry, March 1988, Elsevier

    Prof ABRAHAM WEIZMAN

  964. Up-regulatory effect of triphasic oral contraceptive on platelet 3H-imipramine binding sites

    Article • Psychiatry Research, January 1988, Elsevier

    Prof ABRAHAM WEIZMAN

  965. Clomipramine-Induced Urinary Dysfunction in an Obsessive-Compulsive Adolescent

    Article • Drug Intelligence & Clinical Pharmacy, November 1987, SAGE Publications

    Prof ABRAHAM WEIZMAN

  966. Serotonin 5-HT2 receptor binding on blood platelets - a peripheral marker for depression?

    Article • Life Sciences, November 1987, Elsevier

    Prof ABRAHAM WEIZMAN

  967. Carbamazepine up-regulates the binding of [3H]PK 11195 to platelets of epileptic patients

    Article • European Journal of Pharmacology, September 1987, Elsevier

    Prof ABRAHAM WEIZMAN

  968. The effect of acute and repeated electroconvulsive treatment on plasma β-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients

    Article • Psychopharmacology, September 1987, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  969. Ontogenetic development of peripheral benzodiazepine binding sites in rat brain, heart and lung

    Article • Brain Research, April 1987, Elsevier

    Prof ABRAHAM WEIZMAN

  970. Regulation of central and peripheral benzodiazepine receptors in progesterone-treated rats

    Article • Brain Research, April 1987, Elsevier

    Prof ABRAHAM WEIZMAN

  971. Upregulation of imipramine binding and serotonin uptake by estradiol in female rat brain

    Article • Brain Research, April 1987, Elsevier

    Prof ABRAHAM WEIZMAN

  972. A successful electroconvulsive treatment of neuroleptic malignant syndrome

    Article • Acta Psychiatrica Scandinavica, March 1987, Wiley

    Prof ABRAHAM WEIZMAN

  973. Platelet [3H]imipramine binding in autism and schizophrenia

    Article • Psychopharmacology, January 1987, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  974. Neuroleptic Malignant Syndrome

    Article • The British Journal of Psychiatry, September 1986, Royal College of Psychiatrists

    Prof ABRAHAM WEIZMAN

  975. Modulation of peripheral benzodiazepine binding sites following chronic estradiol treatment

    Article • European Journal of Pharmacology, August 1986, Elsevier

    Prof ABRAHAM WEIZMAN

  976. High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients

    Article • American Journal of Psychiatry, March 1986, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  977. Decreased peripheral benzodiazepine binding sites in platelets of neuroleptic-treated schizophrenics

    Article • European Journal of Pharmacology, February 1986, Elsevier

    Prof ABRAHAM WEIZMAN

  978. Sulpiride-induced hyperprolactinemia and impotence in male psychiatric outpatients

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, January 1985, Elsevier

    Prof ABRAHAM WEIZMAN

  979. Behavior Therapy, Pimozide Treatment and Prolactin Secretion in Anorexia Nervosa

    Article • Psychotherapy and Psychosomatics, January 1985, Karger Publishers

    Prof ABRAHAM WEIZMAN

  980. Decreased high affinity 3H-imipramine binding in platelets of enuretic children and adolescents

    Article • Psychiatry Research, January 1985, Elsevier

    Prof ABRAHAM WEIZMAN

  981. Combination of Neuroleptic and Stimulant Treatment in Attention Deficit Disorder with Hyperactivity

    Article • Journal of the American Academy of Child Psychiatry, May 1984, Elsevier

    Prof ABRAHAM WEIZMAN

  982. High dose diazepam treatment and its effect on prolactin secretion in adolescent schizophrenic patients

    Article • Psychopharmacology, March 1984, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  983. Humoral-endorphin blood levels in autistic, schizophrenic and healthy subjects

    Article • Psychopharmacology, March 1984, Springer Science + Business Media

    Prof ABRAHAM WEIZMAN

  984. Basal Plasma HGH and Cortisol Levels and the Effect of Clonidine Administration in Female Migrainous Patients

    Article • Neuropsychobiology, January 1984, Karger Publishers

    Prof ABRAHAM WEIZMAN

  985. Dr. Weizman and Associates Reply

    Article • American Journal of Psychiatry, September 1983, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  986. The Correlation of Increased Serum Prolactin Levels with Decreased Sexual Desire and Activity in Elderly Men

    Article • Journal of the American Geriatrics Society, August 1983, Wiley

    Prof ABRAHAM WEIZMAN

  987. Sexual Dysfunction Associated with Hyperprolactinemia in Males and Females Undergoing Hemodialysis

    Article • Psychosomatic Medicine, June 1983, Wolters Kluwer Health

    Prof ABRAHAM WEIZMAN

  988. Abnormal growth hormone response to TRH in chronic adolescent schizophrenic patients

    Article • The British Journal of Psychiatry, December 1982, Royal College of Psychiatrists

    Prof ABRAHAM WEIZMAN

  989. Abnormal immune response to brain tissue antigen in the syndrome of autism

    Article • American Journal of Psychiatry, November 1982, American Psychiatric Association

    Prof ABRAHAM WEIZMAN

  990. Hyperprolactinemia: A Possible Cause of Sexual Impotence in Male Patients Undergoing Chronic Hemodialysis

    Article • Nephron, January 1980, Karger Publishers

    Prof ABRAHAM WEIZMAN

  991. Hypercalcaemia-Induced Psychopathology in Malignant Diseases

    Article • The British Journal of Psychiatry, October 1979, Royal College of Psychiatrists

    Prof ABRAHAM WEIZMAN

  992. Neurogenetics of Anxiety Disorders

    Article • Wiley

    Prof ABRAHAM WEIZMAN